The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.
An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.
A rare form of DEMENTIA that is sometimes familial. Clinical features include APHASIA; APRAXIA; CONFUSION; ANOMIA; memory loss; and personality deterioration. This pattern is consistent with the pathologic findings of circumscribed atrophy of the poles of the FRONTAL LOBE and TEMPORAL LOBE. Neuronal loss is maximal in the HIPPOCAMPUS, entorhinal cortex, and AMYGDALA. Some ballooned cortical neurons contain argentophylic (Pick) bodies. (From Brain Pathol 1998 Apr;8(2):339-54; Adams et al., Principles of Neurology, 6th ed, pp1057-9)
Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES).
An increase number of repeats of a genomic, tandemly repeated DNA sequence from one generation to the next.
The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus.
Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44)
Lower lateral part of the cerebral hemisphere responsible for auditory, olfactory, and semantic processing. It is located inferior to the lateral fissure and anterior to the OCCIPITAL LOBE.
Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
Observable manifestations of impaired psychological functioning.
A progressive form of dementia characterized by the global loss of language abilities and initial preservation of other cognitive functions. Fluent and nonfluent subtypes have been described. Eventually a pattern of global cognitive dysfunction, similar to ALZHEIMER DISEASE, emerges. Pathologically, there are no Alzheimer or PICK DISEASE like changes, however, spongiform changes of cortical layers II and III are present in the TEMPORAL LOBE and FRONTAL LOBE. (From Brain 1998 Jan;121(Pt 1):115-26)
A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
The observable response of a man or animal to a situation.
A form of frontotemporal lobar degeneration and a progressive form of dementia characterized by motor speech impairment and AGRAMMATISM, with relative sparing of single word comprehension and semantic memory.
A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
A disease marked by repeated episodes of increased bone resorption followed by excessive attempts at repair, resulting in weakened, deformed bones of increased mass. The resultant architecture of the bone assumes a mosaic pattern in which the fibers take on a haphazard pattern instead of the normal parallel symmetry.
A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed)
Diseases characterized by a selective degeneration of the motor neurons of the spinal cord, brainstem, or motor cortex. Clinical subtypes are distinguished by the major site of degeneration. In AMYOTROPHIC LATERAL SCLEROSIS there is involvement of upper, lower, and brainstem motor neurons. In progressive muscular atrophy and related syndromes (see MUSCULAR ATROPHY, SPINAL) the motor neurons in the spinal cord are primarily affected. With progressive bulbar palsy (BULBAR PALSY, PROGRESSIVE), the initial degeneration occurs in the brainstem. In primary lateral sclerosis, the cortical neurons are affected in isolation. (Adams et al., Principles of Neurology, 6th ed, p1089)
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
A multifunctional heterogeneous-nuclear ribonucleoprotein that may play a role in homologous DNA pairing and recombination. The N-terminal portion of protein is a potent transcriptional activator, while the C terminus is required for RNA binding. The name FUS refers to the fact that genetic recombination events result in fusion oncogene proteins (ONCOGENE PROTEINS, FUSION) that contain the N-terminal region of this protein. These fusion proteins have been found in myxoid liposarcoma (LIPOSARCOMA, MYXOID) and acute myeloid leukemia.
The age, developmental stage, or period of life at which a disease or the initial symptoms or manifestations of a disease appear in an individual.
A specific pair of GROUP E CHROMOSOMES of the human chromosome classification.
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
Disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.
Loss of the ability to form new memories beyond a certain point in time. This condition may be organic or psychogenic in origin. Organically induced anterograde amnesia may follow CRANIOCEREBRAL TRAUMA; SEIZURES; ANOXIA; and other conditions which adversely affect neural structures associated with memory formation (e.g., the HIPPOCAMPUS; FORNIX (BRAIN); MAMMILLARY BODIES; and ANTERIOR THALAMIC NUCLEI). (From Memory 1997 Jan-Mar;5(1-2):49-71)
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments (neurofilaments and microtubules). These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: (1) the intermediate filaments: medium- and high-molecular-weight neurofilaments; (2) the microtubule-associated proteins map-2 and tau; (3) actin; and (4) UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease.
Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Postmortem examination of the body.
Type of declarative memory, consisting of personal memory in contrast to general knowledge.
A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
Lack of emotion or emotional expression; a disorder of motivation that persists over time.
Behaviors which are at variance with the expected social norm and which affect other individuals.
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Circumscribed masses of foreign or metabolically inactive materials, within the CELL NUCLEUS. Some are VIRAL INCLUSION BODIES.
The ability to attribute mental states (e.g., beliefs, desires, feelings, intentions, thoughts, etc.) to self and to others, allowing an individual to understand and infer behavior on the basis of the mental states. Difference or deficit in theory of mind is associated with ASPERGER SYNDROME; AUTISTIC DISORDER; and SCHIZOPHRENIA, etc.
A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.
Standardized clinical interview used to assess current psychopathology by scaling patient responses to the questions.
Loss of the ability to recall information that had been previously encoded in memory prior to a specified or approximate point in time. This process may be organic or psychogenic in origin. Organic forms may be associated with CRANIOCEREBRAL TRAUMA; CEREBROVASCULAR ACCIDENTS; SEIZURES; DEMENTIA; and a wide variety of other conditions that impair cerebral function. (From Adams et al., Principles of Neurology, 6th ed, pp426-9)
Methods and procedures for the diagnosis of diseases of the nervous system, central and peripheral, or demonstration of neurologic function or dysfunction.
Intellectual or mental process whereby an organism obtains knowledge.
A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.
Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition.
The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
Large subcortical nuclear masses derived from the telencephalon and located in the basal regions of the cerebral hemispheres.
A state in which attention is largely directed inward upon one's self.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
A specific pair of GROUP C CHROMSOMES of the human chromosome classification.
Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.
Conditions characterized by deficiencies of comprehension or expression of written and spoken forms of language. These include acquired and developmental disorders.
Loss of higher cortical functions with retained awareness due to multiple cortical or subcortical CEREBRAL INFARCTION. Memory, judgment, attention span, and impulse control are often impaired, and may be accompanied by PSEUDOBULBAR PALSY; HEMIPARESIS; reflex abnormalities, and other signs of localized neurologic dysfunction. (From Adams et al., Principles of Neurology, 6th ed, p1060)
Persons who provide care to those who need supervision or assistance in illness or disability. They may provide the care in the home, in a hospital, or in an institution. Although caregivers include trained medical, nursing, and other health personnel, the concept also refers to parents, spouses, or other family members, friends, members of the clergy, teachers, social workers, fellow patients.
A highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These "ubiquitinated" proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.
A medical specialty concerned with the study of the structures, functions, and diseases of the nervous system.
A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.
A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
Any behavior caused by or affecting another individual, usually of the same species.
The production of a dense fibrous network of neuroglia; includes astrocytosis, which is a proliferation of astrocytes in the area of a degenerative lesion.
Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
Collections of illustrative plates, charts, etc., usually with explanatory captions.
A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)
Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein.
Behavioral manifestations of cerebral dominance in which there is preferential use and superior functioning of either the left or the right side, as in the preferred use of the right hand or right foot.
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.
Tests designed to assess language behavior and abilities. They include tests of vocabulary, comprehension, grammar and functional use of language, e.g., Development Sentence Scoring, Receptive-Expressive Emergent Language Scale, Parsons Language Sample, Utah Test of Language Development, Michigan Language Inventory and Verbal Language Development Scale, Illinois Test of Psycholinguistic Abilities, Northwestern Syntax Screening Test, Peabody Picture Vocabulary Test, Ammons Full-Range Picture Vocabulary Test, and Assessment of Children's Language Comprehension.
Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness.
A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA.
The use of diffusion ANISOTROPY data from diffusion magnetic resonance imaging results to construct images based on the direction of the faster diffusing molecules.
Those affective states which can be experienced and have arousing and motivational properties.
Upper central part of the cerebral hemisphere. It is located posterior to central sulcus, anterior to the OCCIPITAL LOBE, and superior to the TEMPORAL LOBES.
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
One of the convolutions on the medial surface of the CEREBRAL HEMISPHERES. It surrounds the rostral part of the brain and CORPUS CALLOSUM and forms part of the LIMBIC SYSTEM.
A group of enzymes which catalyze the hydrolysis of ATP. The hydrolysis reaction is usually coupled with another function such as transporting Ca(2+) across a membrane. These enzymes may be dependent on Ca(2+), Mg(2+), anions, H+, or DNA.
The relationships between symbols and their meanings.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
A verbal or nonverbal means of communicating ideas or feelings.
Time period from 1801 through 1900 of the common era.
Observable changes of expression in the face in response to emotional stimuli.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
Includes both producing and responding to words, either written or spoken.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME.
An aphasia characterized by impairment of expressive LANGUAGE (speech, writing, signs) and relative preservation of receptive language abilities (i.e., comprehension). This condition is caused by lesions of the motor association cortex in the FRONTAL LOBE (BROCA AREA and adjacent cortical and white matter regions).
The act or fact of grasping the meaning, nature, or importance of; understanding. (American Heritage Dictionary, 4th ed) Includes understanding by a patient or research subject of information disclosed orally or in writing.
A characteristic symptom complex.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
A statistical analytic technique used with discrete dependent variables, concerned with separating sets of observed values and allocating new values. It is sometimes used instead of regression analysis.
Posterior portion of the CEREBRAL HEMISPHERES responsible for processing visual sensory information. It is located posterior to the parieto-occipital sulcus and extends to the preoccipital notch.
A meshlike structure composed of interconnecting nerve cells that are separated at the synaptic junction or joined to one another by cytoplasmic processes. In invertebrates, for example, the nerve net allows nerve impulses to spread over a wide area of the net because synapses can pass information in any direction.
Descriptive anatomy based on three-dimensional imaging (IMAGING, THREE-DIMENSIONAL) of the body, organs, and structures using a series of computer multiplane sections, displayed by transverse, coronal, and sagittal analyses. It is essential to accurate interpretation by the radiologist of such techniques as ultrasonic diagnosis, MAGNETIC RESONANCE IMAGING, and computed tomography (TOMOGRAPHY, X-RAY COMPUTED). (From Lane & Sharfaei, Modern Sectional Anatomy, 1992, Preface)

Standardised measurement of self-awareness deficits in FTD and AD. (1/291)

 (+info)

Molecular neuropathology of TDP-43 proteinopathies. (2/291)

 (+info)

Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls. (3/291)

 (+info)

Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia, and Alzheimer's disease. (4/291)

 (+info)

Rest-activity and behavioral disruption in a patient with frontotemporal dementia. (5/291)

 (+info)

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. (6/291)

 (+info)

Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia. (7/291)

 (+info)

Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching. (8/291)

 (+info)

Frontotemporal dementia (FTD) is a group of disorders caused by progressive degeneration of the frontal and temporal lobes of the brain. These areas of the brain are associated with personality, behavior, and language.

There are three main types of FTD:

1. Behavioral variant FTD (bvFTD): This type is characterized by changes in personality, behavior, and judgment. Individuals may become socially inappropriate, emotionally indifferent, or impulsive. They may lose interest in things they used to enjoy and have difficulty with tasks that require planning and organization.

2. Primary progressive aphasia (PPA): This type affects language abilities. There are two main subtypes of PPA: semantic dementia and progressive nonfluent aphasia. Semantic dementia is characterized by difficulty understanding words and objects, while progressive nonfluent aphasia is characterized by problems with speech production and articulation.

3. Motor neuron disease (MND) associated FTD: Some individuals with FTD may also develop motor neuron disease, which affects the nerves that control muscle movement. This can lead to weakness, stiffness, and wasting of muscles, as well as difficulty swallowing and speaking.

FTD is a degenerative disorder, meaning that symptoms get worse over time. There is no cure for FTD, but there are treatments available to help manage symptoms and improve quality of life. The exact cause of FTD is not known, but it is believed to be related to abnormalities in certain proteins in the brain. In some cases, FTD may run in families and be caused by genetic mutations.

Dementia is a broad term that describes a decline in cognitive functioning, including memory, language, problem-solving, and judgment, severe enough to interfere with daily life. It is not a specific disease but rather a group of symptoms that may be caused by various underlying diseases or conditions. Alzheimer's disease is the most common cause of dementia, accounting for 60-80% of cases. Other causes include vascular dementia, Lewy body dementia, frontotemporal dementia, and Huntington's disease.

The symptoms of dementia can vary widely depending on the cause and the specific areas of the brain that are affected. However, common early signs of dementia may include:

* Memory loss that affects daily life
* Difficulty with familiar tasks
* Problems with language or communication
* Difficulty with visual and spatial abilities
* Misplacing things and unable to retrace steps
* Decreased or poor judgment
* Withdrawal from work or social activities
* Changes in mood or behavior

Dementia is a progressive condition, meaning that symptoms will gradually worsen over time. While there is currently no cure for dementia, early diagnosis and treatment can help slow the progression of the disease and improve quality of life for those affected.

Frontotemporal lobar degeneration (FTLD) is a group of disorders characterized by the progressive degeneration of the frontal and temporal lobes of the brain. These areas of the brain are involved in decision-making, behavior, emotion, and language. FTLD can be divided into several subtypes based on the specific clinical features and the underlying protein abnormalities.

The three main subtypes of FTLD are:

1. Behavioral variant frontotemporal dementia (bvFTD): This subtype is characterized by changes in personality, behavior, and judgment. People with bvFTD may lose their social inhibitions, become impulsive, or develop compulsive behaviors. They may also have difficulty with emotional processing and empathy.
2. Primary progressive aphasia (PPA): This subtype is characterized by the gradual deterioration of language skills. People with PPA may have difficulty speaking, understanding spoken or written language, or both. There are three subtypes of PPA: nonfluent/agrammatic variant, semantic variant, and logopenic variant.
3. Motor neuron disease (MND) with FTLD: This subtype is characterized by the degeneration of motor neurons, which are the nerve cells responsible for controlling voluntary muscle movements. People with MND with FTLD may develop symptoms of amyotrophic lateral sclerosis (ALS), such as muscle weakness, stiffness, and twitching, as well as cognitive and behavioral changes associated with FTLD.

The underlying protein abnormalities in FTLD include:

1. Tau protein: In some forms of FTLD, the tau protein accumulates and forms clumps called tangles inside nerve cells. This is also seen in Alzheimer's disease.
2. TDP-43 protein: In other forms of FTLD, the TDP-43 protein accumulates and forms clumps inside nerve cells.
3. Fused in sarcoma (FUS) protein: In a small number of cases, the FUS protein accumulates and forms clumps inside nerve cells.

FTLD is typically a progressive disorder, meaning that symptoms worsen over time. There is currently no cure for FTLD, but there are treatments available to help manage symptoms and improve quality of life.

Pick's disease, also known as Frontotemporal dementia (FTD), is a rare form of degenerative brain disorder that affects the frontal and temporal lobes of the brain. It is characterized by progressive shrinkage (atrophy) of these regions, resulting in a decline in cognitive abilities, behavioral changes, and language difficulties.

The medical definition of Pick's disease includes the following key features:

1. Progressive deterioration of cognitive functions, including memory, judgment, and problem-solving skills.
2. Changes in personality, emotional blunting, and loss of social inhibitions.
3. Language difficulties, such as difficulty with word finding, grammar, and comprehension.
4. Presence of abnormal protein deposits called Pick bodies or Pick cells in the affected brain regions.
5. Exclusion of other causes of dementia, such as Alzheimer's disease, vascular dementia, or Lewy body dementia.

Pick's disease typically affects people between the ages of 40 and 60, and it tends to progress more rapidly than other forms of dementia. Currently, there is no cure for Pick's disease, and treatment focuses on managing symptoms and improving quality of life.

Tau proteins are a type of microtubule-associated protein (MAP) found primarily in neurons of the central nervous system. They play a crucial role in maintaining the stability and structure of microtubules, which are essential components of the cell's cytoskeleton. Tau proteins bind to and stabilize microtubules, helping to regulate their assembly and disassembly.

In Alzheimer's disease and other neurodegenerative disorders known as tauopathies, tau proteins can become abnormally hyperphosphorylated, leading to the formation of insoluble aggregates called neurofibrillary tangles (NFTs) within neurons. These aggregates disrupt the normal function of microtubules and contribute to the degeneration and death of nerve cells, ultimately leading to cognitive decline and other symptoms associated with these disorders.

DNA repeat expansion is a genetic alteration in which a particular sequence of DNA base pairs is repeated multiple times. In normal genes, these repeats are relatively short and stable, but in certain diseases, the number of repeats can expand beyond a threshold, leading to changes in the structure or function of the gene. This type of mutation is often associated with neurological and neuromuscular disorders, such as Huntington's disease, myotonic dystrophy, and fragile X syndrome. The expanded repeats can also be unstable and may increase in size over generations, leading to more severe symptoms or earlier age of onset.

The frontal lobe is the largest lobes of the human brain, located at the front part of each cerebral hemisphere and situated in front of the parietal and temporal lobes. It plays a crucial role in higher cognitive functions such as decision making, problem solving, planning, parts of social behavior, emotional expressions, physical reactions, and motor function. The frontal lobe is also responsible for what's known as "executive functions," which include the ability to focus attention, understand rules, switch focus, plan actions, and inhibit inappropriate behaviors. It is divided into five areas, each with its own specific functions: the primary motor cortex, premotor cortex, Broca's area, prefrontal cortex, and orbitofrontal cortex. Damage to the frontal lobe can result in a wide range of impairments, depending on the location and extent of the injury.

Atrophy is a medical term that refers to the decrease in size and wasting of an organ or tissue due to the disappearance of cells, shrinkage of cells, or decreased number of cells. This process can be caused by various factors such as disuse, aging, degeneration, injury, or disease.

For example, if a muscle is immobilized for an extended period, it may undergo atrophy due to lack of use. Similarly, certain medical conditions like diabetes, cancer, and heart failure can lead to the wasting away of various tissues and organs in the body.

Atrophy can also occur as a result of natural aging processes, leading to decreased muscle mass and strength in older adults. In general, atrophy is characterized by a decrease in the volume or weight of an organ or tissue, which can have significant impacts on its function and overall health.

Neuropsychological tests are a type of psychological assessment that measures cognitive functions, such as attention, memory, language, problem-solving, and perception. These tests are used to help diagnose and understand the cognitive impact of neurological conditions, including dementia, traumatic brain injury, stroke, Parkinson's disease, and other disorders that affect the brain.

The tests are typically administered by a trained neuropsychologist and can take several hours to complete. They may involve paper-and-pencil tasks, computerized tasks, or interactive activities. The results of the tests are compared to normative data to help identify any areas of cognitive weakness or strength.

Neuropsychological testing can provide valuable information for treatment planning, rehabilitation, and assessing response to treatment. It can also be used in research to better understand the neural basis of cognition and the impact of neurological conditions on cognitive function.

Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. It's the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.

The early signs of the disease include forgetting recent events or conversations. As the disease progresses, a person with Alzheimer's disease will develop severe memory impairment and lose the ability to carry out everyday tasks.

Currently, there's no cure for Alzheimer's disease. However, treatments can temporarily slow the worsening of dementia symptoms and improve quality of life.

Vascular dementia is a type of dementia that is caused by damage to the blood vessels that supply blood to the brain. This damage can result from conditions such as stroke, chronic high blood pressure, diabetes, or other diseases that affect the circulatory system. The interruption in blood flow to the brain can lead to damaged or dead brain cells, which can impair cognitive function and cause symptoms similar to those seen in other types of dementia, such as Alzheimer's disease.

The symptoms of vascular dementia can vary depending on the severity and location of the damage to the blood vessels. However, common symptoms include difficulties with memory, attention, and decision-making; problems with language and speech; changes in mood or behavior; and difficulty walking or performing other physical tasks. Vascular dementia is typically a progressive condition, meaning that the symptoms tend to worsen over time.

It's important to note that vascular dementia can coexist with other types of dementia, such as Alzheimer's disease, and this is known as mixed dementia. Proper diagnosis and management of underlying medical conditions that contribute to vascular dementia can help slow down the progression of cognitive decline and improve quality of life for individuals living with this condition.

The temporal lobe is one of the four main lobes of the cerebral cortex in the brain, located on each side of the head roughly level with the ears. It plays a major role in auditory processing, memory, and emotion. The temporal lobe contains several key structures including the primary auditory cortex, which is responsible for analyzing sounds, and the hippocampus, which is crucial for forming new memories. Damage to the temporal lobe can result in various neurological symptoms such as hearing loss, memory impairment, and changes in emotional behavior.

Tauopathies are a group of neurodegenerative disorders that are characterized by the abnormal accumulation and aggregation of the microtubule-associated protein Tau in neurons and glial cells. These misfolded Tau proteins form insoluble inclusions, such as neurofibrillary tangles (NFTs) and neuropil threads, which are associated with the degeneration and loss of neurons in specific regions of the brain.

Tauopathies include several well-known diseases, such as Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and frontotemporal dementia with Parkinsonism-17 (FTDP-17). The exact cause of Tauopathies remains unclear, but genetic mutations, environmental factors, or a combination of both may contribute to the development and progression of these disorders.

The accumulation of abnormal Tau aggregates is believed to play a central role in the neurodegenerative process, leading to cognitive decline, motor impairment, and other neurological symptoms associated with Tauopathies. The diagnosis of Tauopathies typically involves clinical evaluation, imaging studies, and sometimes postmortem examination of brain tissue. Currently, there are no effective disease-modifying treatments for Tauopathies, but ongoing research is focused on developing therapies that target Tau aggregation and clearance to slow down or halt the progression of these debilitating disorders.

Behavioral symptoms refer to changes or abnormalities in a person's behavior, which may be indicative of an underlying medical or psychological condition. These symptoms can manifest as a wide range of observable behaviors that are unusual, disruptive, or distressing for the individual experiencing them or those around them. Examples of behavioral symptoms include:

1. Agitation: A state of irritability, restlessness, or excitement, often accompanied by aggressive or disruptive behavior.
2. Aggression: Hostile or violent behavior directed towards others, including verbal or physical attacks.
3. Apathy: A lack of interest, motivation, or emotion, often leading to social withdrawal and decreased activity levels.
4. Changes in appetite or sleep patterns: Significant fluctuations in the amount or frequency of food intake or sleep, which can be indicative of various medical or psychological conditions.
5. Disinhibition: A loss of restraint or impulse control, leading to inappropriate behavior in social situations.
6. Hallucinations: Perception of sensory stimuli (such as sight, sound, touch) without an external source, often associated with certain mental illnesses or neurological disorders.
7. Hyperactivity: Increased activity levels, often accompanied by impulsivity and difficulty focusing attention.
8. Impaired judgment: Poor decision-making abilities, often resulting in risky or harmful behavior.
9. Inattention: Difficulty focusing or sustaining attention on a task or activity.
10. Mood changes: Fluctuations in emotional state, such as depression, anxiety, or euphoria.
11. Psychosis: A severe mental disorder characterized by detachment from reality, hallucinations, and disorganized thinking or behavior.
12. Repetitive behaviors: Engaging in repetitive actions or movements, often associated with certain developmental disorders or neurological conditions.
13. Social withdrawal: Avoidance of social interactions or activities, often indicative of depression, anxiety, or other mental health concerns.
14. Thought disturbances: Disorganized or disrupted thinking patterns, such as racing thoughts, tangential thinking, or loose associations between ideas.

Behavioral symptoms can be caused by various factors, including medical conditions (such as infections, brain injuries, or neurodegenerative diseases), mental health disorders (such as depression, anxiety, bipolar disorder, or schizophrenia), substance abuse, and environmental factors (such as stress or trauma). Accurate assessment and diagnosis are crucial for determining appropriate treatment interventions.

Primary Progressive Aphasia (PPA) is a neurological disorder characterized by progressive loss of language capabilities, while other cognitive abilities remain preserved. It is a type of dementia that primarily affects speech and language. Unlike other forms of aphasia that result from stroke or head injury, PPA is degenerative and gets worse over time.

There are three main types of PPA:

1. Semantic Variant PPA (svPPA): This type is characterized by difficulty in understanding words and objects, despite having no trouble with the mechanics of speech or writing. Over time, people with svPPA may lose their ability to understand spoken or written language, as well as to recognize objects and faces.

2. Nonfluent/Agrammatic Variant PPA (nfvPPA): This type is characterized by difficulty with speaking and writing, including producing grammatical sentences and articulating words. People with nfvPPA may also have problems with understanding spoken language, particularly when it comes to complex sentences or ambiguous phrases.

3. Logopenic Variant PPA (lvPPA): This type is characterized by difficulty with word-finding and sentence repetition, while speech remains fluent. People with lvPPA may also have problems with understanding spoken language, particularly when it comes to complex sentences or ambiguous phrases.

The exact cause of PPA is not known, but it is believed to be related to degeneration of specific areas of the brain involved in language processing, such as Broca's area and Wernicke's area. There is currently no cure for PPA, but speech and language therapy can help to slow down the progression of the disorder and improve communication skills.

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord responsible for controlling voluntary muscle movements, such as speaking, walking, breathing, and swallowing. The condition is characterized by the degeneration of motor neurons in the brain (upper motor neurons) and spinal cord (lower motor neurons), leading to their death.

The term "amyotrophic" comes from the Greek words "a" meaning no or negative, "myo" referring to muscle, and "trophic" relating to nutrition. When a motor neuron degenerates and can no longer send impulses to the muscle, the muscle becomes weak and eventually atrophies due to lack of use.

The term "lateral sclerosis" refers to the hardening or scarring (sclerosis) of the lateral columns of the spinal cord, which are primarily composed of nerve fibers that carry information from the brain to the muscles.

ALS is often called Lou Gehrig's disease, named after the famous American baseball player who was diagnosed with the condition in 1939. The exact cause of ALS remains unknown, but it is believed to involve a combination of genetic and environmental factors. There is currently no cure for ALS, and treatment primarily focuses on managing symptoms and maintaining quality of life.

The progression of ALS varies from person to person, with some individuals experiencing rapid decline over just a few years, while others may have a more slow-progressing form of the disease that lasts several decades. The majority of people with ALS die from respiratory failure within 3 to 5 years after the onset of symptoms. However, approximately 10% of those affected live for 10 or more years following diagnosis.

'Behavior' is a term used in the medical and scientific community to describe the actions or reactions of an individual in response to internal or external stimuli. It can be observed and measured, and it involves all the responses of a person, including motor responses, emotional responses, and cognitive responses. Behaviors can be voluntary or involuntary, adaptive or maladaptive, and normal or abnormal. They can also be influenced by genetic, physiological, environmental, and social factors. In a medical context, the study of behavior is often relevant to understanding and treating various mental health conditions, such as anxiety disorders, mood disorders, and personality disorders.

Primary Progressive Nonfluent Aphasia (PPNA) is a rare type of dementia that primarily affects language abilities. According to the National Aphasia Association, it is characterized by progressive difficulty with speaking and writing, while comprehension of single words and object knowledge remains relatively intact. The "nonfluent" descriptor refers to the hesitant, effortful, and halting speech pattern observed in individuals with this condition.

The Medical Subject Headings (MeSH) term provided by the National Library of Medicine defines PPNA as:

"A progressive aphasia characterized by agrammatism and/or anomia with relatively preserved single word comprehension and object knowledge. This condition often, but not always, begins between the sixth and seventh decades of life. As the disorder progresses, it may be accompanied by ideomotor apraxia, alien hand syndrome, and elements of corticobasal degeneration."

It is important to note that PPNA is a clinical diagnosis, and there are currently no established biomarkers or imaging techniques to definitively diagnose this condition. The underlying neuropathology may vary between individuals with PPNA, but the most common causes include frontotemporal lobar degeneration (FTLD) and corticobasal degeneration (CBD).

Progressive Supranuclear Palsy (PSP) is a rare neurological disorder characterized by the progressive degeneration of brain cells that regulate movement, thoughts, behavior, and eye movements. The term "supranuclear" refers to the location of the damage in the brain, specifically above the level of the "nuclei" which are clusters of nerve cells that control voluntary movements.

The most common early symptom of PSP is a loss of balance and difficulty coordinating eye movements, particularly vertical gaze. Other symptoms may include stiffness or rigidity of muscles, slowness of movement, difficulty swallowing, changes in speech and writing, and cognitive decline leading to dementia.

PSP typically affects people over the age of 60, and its progression can vary from person to person. Currently, there is no cure for PSP, and treatment is focused on managing symptoms and maintaining quality of life.

Osteitis deformans, also known as Paget's disease of bone, is a chronic disorder of the bone characterized by abnormal turnover and remodeling of the bone. In this condition, the bone becomes enlarged, thickened, and deformed due to excessive and disorganized bone formation and resorption.

The process begins when the bone-remodeling cycle is disrupted, leading to an imbalance between the activity of osteoclasts (cells that break down bone) and osteoblasts (cells that form new bone). In Paget's disease, osteoclasts become overactive and increase bone resorption, followed by an overzealous response from osteoblasts, which attempt to repair the damage but do so in a disorganized manner.

The affected bones can become weakened, prone to fractures, and may cause pain, deformities, or other complications such as arthritis, hearing loss, or neurological symptoms if the skull or spine is involved. The exact cause of Paget's disease remains unknown, but it is believed that genetic and environmental factors play a role in its development.

Early diagnosis and treatment can help manage the symptoms and prevent complications associated with osteitis deformans. Treatment options include medications to slow down bone turnover, pain management, and orthopedic interventions when necessary.

Inclusion bodies are abnormal, intracellular accumulations or aggregations of various misfolded proteins, protein complexes, or other materials within the cells of an organism. They can be found in various tissues and cell types and are often associated with several pathological conditions, including infectious diseases, neurodegenerative disorders, and genetic diseases.

Inclusion bodies can vary in size, shape, and location depending on the specific disease or condition. Some inclusion bodies have a characteristic appearance under the microscope, such as eosinophilic (pink) staining with hematoxylin and eosin (H&E) histological stain, while others may require specialized stains or immunohistochemical techniques to identify the specific misfolded proteins involved.

Examples of diseases associated with inclusion bodies include:

1. Infectious diseases: Some viral infections, such as HIV, hepatitis B and C, and herpes simplex virus, can lead to the formation of inclusion bodies within infected cells.
2. Neurodegenerative disorders: Several neurodegenerative diseases are characterized by the presence of inclusion bodies, including Alzheimer's disease (amyloid-beta plaques and tau tangles), Parkinson's disease (Lewy bodies), Huntington's disease (Huntingtin aggregates), and amyotrophic lateral sclerosis (TDP-43 and SOD1 inclusions).
3. Genetic diseases: Certain genetic disorders, such as Danon disease, neuronal intranuclear inclusion disease, and some lysosomal storage disorders, can also present with inclusion bodies due to the accumulation of abnormal proteins or metabolic products within cells.

The exact role of inclusion bodies in disease pathogenesis remains unclear; however, they are often associated with cellular dysfunction, oxidative stress, and increased inflammation, which can contribute to disease progression and neurodegeneration.

Motor Neuron Disease (MND) is a progressive neurodegenerative disorder that affects the motor neurons, which are nerve cells in the brain and spinal cord responsible for controlling voluntary muscles involved in movement, speaking, breathing, and swallowing. As the motor neurons degenerate and die, they stop sending signals to the muscles, causing them to weaken, waste away (atrophy), and eventually lead to paralysis.

There are several types of MND, including:

1. Amyotrophic Lateral Sclerosis (ALS): Also known as Lou Gehrig's disease, this is the most common form of MND. It affects both upper and lower motor neurons, causing muscle weakness, stiffness, twitching, and atrophy throughout the body.
2. Progressive Bulbar Palsy (PBP): This type primarily affects the bulbar muscles in the brainstem, which control speech, swallowing, and chewing. Patients with PBP experience difficulties with speaking, slurred speech, and problems swallowing and may also have weak facial muscles and limb weakness.
3. Primary Lateral Sclerosis (PLS): This form of MND affects only the upper motor neurons, causing muscle stiffness, spasticity, and weakness, primarily in the legs. PLS progresses more slowly than ALS, and patients usually maintain their ability to speak and swallow for a longer period.
4. Progressive Muscular Atrophy (PMA): This type of MND affects only the lower motor neurons, causing muscle wasting, weakness, and fasciculations (muscle twitches). PMA progresses more slowly than ALS but can still be severely disabling over time.
5. Spinal Muscular Atrophy (SMA): This is a genetic form of MND that typically presents in infancy or childhood, although adult-onset forms exist. SMA affects the lower motor neurons in the spinal cord, causing muscle weakness and atrophy, primarily in the legs and trunk.

The exact cause of Motor Neuron Disease is not fully understood, but it is believed to involve a combination of genetic, environmental, and lifestyle factors. There is currently no cure for MND, and treatment focuses on managing symptoms, maintaining quality of life, and slowing disease progression through various therapies and medications.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Inclusion body myositis (IBM) is a rare inflammatory muscle disease characterized by progressive weakness and wasting (atrophy) of skeletal muscles. The term "inclusion body" refers to the presence of abnormal protein accumulations within muscle fibers, which are observed under a microscope during muscle biopsy. These inclusions are primarily composed of aggregated forms of amyloid-β and tau proteins, similar to those found in neurodegenerative disorders like Alzheimer's disease.

IBM typically affects individuals over 50 years old, and it is more common in men than women. The disease usually starts with weakness in the wrist and finger flexors, making it difficult to perform tasks such as gripping, buttoning shirts, or lifting objects. Over time, the weakness spreads to other muscle groups, including the thigh muscles (quadriceps), resulting in difficulty climbing stairs or rising from a seated position.

The exact cause of inclusion body myositis remains unclear; however, both immune-mediated and degenerative mechanisms are believed to contribute to its pathogenesis. Currently, there is no cure for IBM, and treatment options are primarily aimed at managing symptoms and improving quality of life. Immunosuppressive medications may be used to target the inflammatory component of the disease; however, their efficacy varies among patients. Physical therapy and exercise programs can help maintain muscle strength and function as much as possible.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

FUS (Fused in Sarcoma) is a protein that in humans is encoded by the FUS gene. It is primarily located in the nucleus of the cell, but can also be found in the cytoplasm. FUS belongs to the family of RNA-binding proteins, which means it has the ability to bind to RNA molecules and play a role in post-transcriptional regulation of gene expression.

FUS has several functions, including:

1. Transcriptional regulation: FUS can interact with transcription factors and modulate the transcription of genes.
2. mRNA processing: FUS is involved in various aspects of mRNA processing, such as splicing, transport, localization, and stability.
3. DNA repair: FUS plays a role in DNA damage response and repair mechanisms.
4. Translational regulation: FUS can also regulate translation by interacting with ribosomes and other translational factors.

Mutations in the FUS gene have been associated with several neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). These mutations often lead to an abnormal cytoplasmic accumulation of FUS protein, which can form aggregates and contribute to the pathogenesis of these diseases.

The "age of onset" is a medical term that refers to the age at which an individual first develops or displays symptoms of a particular disease, disorder, or condition. It can be used to describe various medical conditions, including both physical and mental health disorders. The age of onset can have implications for prognosis, treatment approaches, and potential causes of the condition. In some cases, early onset may indicate a more severe or progressive course of the disease, while late-onset symptoms might be associated with different underlying factors or etiologies. It is essential to provide accurate and precise information regarding the age of onset when discussing a patient's medical history and treatment plan.

Human chromosome pair 17 consists of two rod-shaped structures present in the nucleus of each human cell. Each chromosome is made up of DNA tightly coiled around histone proteins, forming a complex called chromatin. Chromosomes carry genetic information in the form of genes, which are segments of DNA that contain instructions for the development and function of an organism.

Human cells typically have 23 pairs of chromosomes, for a total of 46 chromosomes. Pair 17 is one of the autosomal pairs, meaning it is not a sex chromosome (X or Y). Chromosome 17 is a medium-sized chromosome and contains an estimated 800 million base pairs of DNA. It contains approximately 1,500 genes that provide instructions for making proteins and regulating various cellular processes.

Chromosome 17 is associated with several genetic disorders, including inherited cancer syndromes such as Li-Fraumeni syndrome and hereditary nonpolyposis colorectal cancer (HNPCC). Mutations in genes located on chromosome 17 can increase the risk of developing various types of cancer, including breast, ovarian, colon, and pancreatic cancer.

Neurodegenerative diseases are a group of disorders characterized by progressive and persistent loss of neuronal structure and function, often leading to cognitive decline, functional impairment, and ultimately death. These conditions are associated with the accumulation of abnormal protein aggregates, mitochondrial dysfunction, oxidative stress, chronic inflammation, and genetic mutations in the brain. Examples of neurodegenerative diseases include Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis (ALS), and Spinal Muscular Atrophy (SMA). The underlying causes and mechanisms of these diseases are not fully understood, and there is currently no cure for most neurodegenerative disorders. Treatment typically focuses on managing symptoms and slowing disease progression.

Cognitive disorders are a category of mental health disorders that primarily affect cognitive abilities including learning, memory, perception, and problem-solving. These disorders can be caused by various factors such as brain injury, degenerative diseases, infection, substance abuse, or developmental disabilities. Examples of cognitive disorders include dementia, amnesia, delirium, and intellectual disability. It's important to note that the specific definition and diagnostic criteria for cognitive disorders may vary depending on the medical source or classification system being used.

TDP-43 proteinopathies refer to a group of neurodegenerative disorders characterized by the abnormal accumulation and aggregation of the TAR DNA-binding protein 43 (TDP-43) in neuronal and glial cells. The accumulated TDP-43 forms inclusions that are rich in ubiquitin and are a hallmark of these disorders.

TDP-43 is a nuclear protein involved in various cellular processes, including transcription, splicing, and transport of RNA. In TDP-43 proteinopathies, the protein undergoes post-translational modifications that lead to its mislocalization from the nucleus to the cytoplasm, where it forms aggregates.

TDP-43 proteinopathies include several neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and Alzheimer's disease (AD). In ALS, TDP-43 pathology is present in almost all cases, while in FTLD, it is found in about half of the cases. In AD, TDP-43 pathology is less common but still significant, particularly in patients with coexisting dementia.

TDP-43 proteinopathies are associated with various clinical manifestations depending on the specific disorder and the extent and location of TDP-43 aggregation. These manifestations include motor neuron degeneration, cognitive decline, behavioral changes, and language impairments. The underlying mechanisms leading to TDP-43 mislocalization and aggregation are not fully understood but are thought to involve genetic, environmental, and aging factors.

Anterograde amnesia is a specific type of memory loss where a person has difficulty forming new memories or learning and retaining new information after the onset of the amnesia. It is often caused by damage to certain parts of the brain, such as the hippocampus and surrounding structures, which play a crucial role in the formation of new memories.

In anterograde amnesia, people may have trouble remembering events that occurred after the onset of their memory impairment, while their ability to recall remote memories or those that were formed before the onset of the amnesia is typically preserved. The severity of anterograde amnesia can vary widely, from mild difficulty with learning new information to a complete inability to form any new memories.

Anterograde amnesia can be caused by various factors, including brain injury, infection, stroke, alcohol or drug abuse, seizures, and certain medical conditions such as Wernicke-Korsakoff syndrome, which is often associated with chronic alcoholism. Treatment for anterograde amnesia depends on the underlying cause and may involve medication, rehabilitation, or other interventions to help improve memory function.

Parkinsonian disorders are a group of neurological conditions characterized by motor symptoms such as bradykinesia (slowness of movement), rigidity, resting tremor, and postural instability. These symptoms are caused by the degeneration of dopamine-producing neurons in the brain, particularly in the substantia nigra pars compacta.

The most common Parkinsonian disorder is Parkinson's disease (PD), which is a progressive neurodegenerative disorder. However, there are also several other secondary Parkinsonian disorders, including:

1. Drug-induced parkinsonism: This is caused by the use of certain medications, such as antipsychotics and metoclopramide.
2. Vascular parkinsonism: This is caused by small vessel disease in the brain, which can lead to similar symptoms as PD.
3. Dementia with Lewy bodies (DLB): This is a type of dementia that shares some features with PD, such as the presence of alpha-synuclein protein clumps called Lewy bodies.
4. Progressive supranuclear palsy (PSP): This is a rare brain disorder that affects movement, gait, and eye movements.
5. Multiple system atrophy (MSA): This is a progressive neurodegenerative disorder that affects multiple systems in the body, including the autonomic nervous system, motor system, and cerebellum.
6. Corticobasal degeneration (CBD): This is a rare neurological disorder that affects both movement and cognition.

It's important to note that while these disorders share some symptoms with PD, they have different underlying causes and may require different treatments.

Neurofibrillary tangles are a pathological hallmark of several neurodegenerative disorders, most notably Alzheimer's disease. They are intracellular inclusions composed of abnormally phosphorylated and aggregated tau protein, which forms paired helical filaments. These tangles accumulate within the neurons, leading to their dysfunction and eventual death. The presence and density of neurofibrillary tangles are strongly associated with cognitive decline and disease progression in Alzheimer's disease and other related dementias.

Intercellular signaling peptides and proteins are molecules that mediate communication and interaction between different cells in living organisms. They play crucial roles in various biological processes, including cell growth, differentiation, migration, and apoptosis (programmed cell death). These signals can be released into the extracellular space, where they bind to specific receptors on the target cell's surface, triggering intracellular signaling cascades that ultimately lead to a response.

Peptides are short chains of amino acids, while proteins are larger molecules made up of one or more polypeptide chains. Both can function as intercellular signaling molecules by acting as ligands for cell surface receptors or by being cleaved from larger precursor proteins and released into the extracellular space. Examples of intercellular signaling peptides and proteins include growth factors, cytokines, chemokines, hormones, neurotransmitters, and their respective receptors.

These molecules contribute to maintaining homeostasis within an organism by coordinating cellular activities across tissues and organs. Dysregulation of intercellular signaling pathways has been implicated in various diseases, such as cancer, autoimmune disorders, and neurodegenerative conditions. Therefore, understanding the mechanisms underlying intercellular signaling is essential for developing targeted therapies to treat these disorders.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

An autopsy, also known as a post-mortem examination or obduction, is a medical procedure in which a qualified professional (usually a pathologist) examines a deceased person's body to determine the cause and manner of death. This process may involve various investigative techniques, such as incisions to study internal organs, tissue sampling, microscopic examination, toxicology testing, and other laboratory analyses. The primary purpose of an autopsy is to gather objective evidence about the medical conditions and factors contributing to the individual's demise, which can be essential for legal, insurance, or public health purposes. Additionally, autopsies can provide valuable insights into disease processes and aid in advancing medical knowledge.

Episodic memory is a type of declarative (explicit) memory that involves the ability to recall and mentally reexperience specific events or episodes, including their temporal and spatial contexts. It is the memory for particular events or episodes that are embedded in a personal autobiographical timeline, along with the details of what happened, where it happened, who was involved, and when it happened. Episodic memories are often formed through conscious effort and can be voluntarily retrieved. They are susceptible to interference and decay over time, making them less reliable than other types of memory.

Lewy body disease, also known as dementia with Lewy bodies, is a type of progressive degenerative dementia that affects thinking, behavior, and movement. It's named after Dr. Friedrich Lewy, the scientist who discovered the abnormal protein deposits, called Lewy bodies, that are characteristic of this disease.

Lewy bodies are made up of a protein called alpha-synuclein and are found in the brain cells of individuals with Lewy body disease. These abnormal protein deposits are also found in people with Parkinson's disease, but they are more widespread in Lewy body disease, affecting multiple areas of the brain.

The symptoms of Lewy body disease can vary from person to person, but they often include:

* Cognitive decline, such as memory loss, confusion, and difficulty with problem-solving
* Visual hallucinations and delusions
* Parkinsonian symptoms, such as stiffness, tremors, and difficulty walking or moving
* Fluctuations in alertness and attention
* REM sleep behavior disorder, where a person acts out their dreams during sleep

Lewy body disease is a progressive condition, which means that the symptoms get worse over time. Currently, there is no cure for Lewy body disease, but medications can help manage some of the symptoms.

Apathy is a lack of feeling, emotion, interest, or concern about something. In medical terms, it's often described as a loss of motivation or a decreased level of enthusiasm or concern for activities or events that one would normally care about. Apathy can be a symptom of various medical and neurological conditions, such as depression, dementia, traumatic brain injury, or Parkinson's disease. It can also be a side effect of certain medications. If severe or persistent, it can significantly impact a person's quality of life and ability to function in daily activities.

Social behavior disorders are a category of mental health conditions that are characterized by significant and persistent patterns of socially disruptive behavior. These behaviors may include aggression, impulsivity, defiance, and opposition to authority, which can interfere with an individual's ability to function in social, academic, or occupational settings.

Social behavior disorders can manifest in a variety of ways, depending on the age and developmental level of the individual. In children and adolescents, common examples include oppositional defiant disorder (ODD), conduct disorder (CD), and disruptive mood dysregulation disorder (DMDD). Adults with social behavior disorders may exhibit antisocial personality disorder or other related conditions.

It is important to note that social behavior disorders are not the result of poor parenting or a lack of discipline, but rather are thought to be caused by a combination of genetic, environmental, and neurobiological factors. Treatment for social behavior disorders typically involves a combination of behavioral therapy, medication, and social skills training.

Basal ganglia diseases are a group of neurological disorders that affect the function of the basal ganglia, which are clusters of nerve cells located deep within the brain. The basal ganglia play a crucial role in controlling movement and coordination. When they are damaged or degenerate, it can result in various motor symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and difficulty with balance and walking.

Some examples of basal ganglia diseases include:

1. Parkinson's disease - a progressive disorder that affects movement due to the death of dopamine-producing cells in the basal ganglia.
2. Huntington's disease - an inherited neurodegenerative disorder that causes uncontrolled movements, emotional problems, and cognitive decline.
3. Dystonia - a movement disorder characterized by sustained or intermittent muscle contractions that cause twisting and repetitive movements or abnormal postures.
4. Wilson's disease - a rare genetic disorder that causes excessive copper accumulation in the liver and brain, leading to neurological and psychiatric symptoms.
5. Progressive supranuclear palsy (PSP) - a rare brain disorder that affects movement, gait, and balance, as well as speech and swallowing.
6. Corticobasal degeneration (CBD) - a rare neurological disorder characterized by progressive loss of nerve cells in the cerebral cortex and basal ganglia, leading to stiffness, rigidity, and difficulty with movement and coordination.

Treatment for basal ganglia diseases varies depending on the specific diagnosis and symptoms but may include medication, surgery, physical therapy, or a combination of these approaches.

Intranuclear inclusion bodies are abnormal, rounded structures found within the nucleus of a cell. They are composed of aggregated proteins or other cellular components and can be associated with various viral infections and certain genetic disorders. These inclusion bodies can interfere with normal nuclear functions, leading to cell damage and contributing to the pathogenesis of diseases such as cytomegalovirus infection, rabies, and some forms of neurodegenerative disorders like polyglutamine diseases. The presence of intranuclear inclusion bodies is often used in diagnostic pathology to help identify specific underlying conditions.

Theory of Mind (ToM) is not a medical term per se, but rather a concept from psychology and cognitive science. It refers to the ability to attribute mental states to oneself and others, understanding that others have beliefs, desires, intentions, and perspectives that are different from one's own. This cognitive skill enables us to explain and predict people's behaviors based on their mental states, fostering social cognition and interaction.

While ToM is not a medical definition itself, impairments in Theory of Mind have been associated with various medical and neurodevelopmental conditions, such as autism spectrum disorder (ASD), schizophrenia, and other psychiatric disorders. In these cases, difficulties in understanding others' mental states may lead to challenges in social communication and interaction.

Computer-assisted image processing is a medical term that refers to the use of computer systems and specialized software to improve, analyze, and interpret medical images obtained through various imaging techniques such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, and others.

The process typically involves several steps, including image acquisition, enhancement, segmentation, restoration, and analysis. Image processing algorithms can be used to enhance the quality of medical images by adjusting contrast, brightness, and sharpness, as well as removing noise and artifacts that may interfere with accurate diagnosis. Segmentation techniques can be used to isolate specific regions or structures of interest within an image, allowing for more detailed analysis.

Computer-assisted image processing has numerous applications in medical imaging, including detection and characterization of lesions, tumors, and other abnormalities; assessment of organ function and morphology; and guidance of interventional procedures such as biopsies and surgeries. By automating and standardizing image analysis tasks, computer-assisted image processing can help to improve diagnostic accuracy, efficiency, and consistency, while reducing the potential for human error.

The Medical Definition of 'Mental Status Schedule' is:

A standardized interview and examination tool used by mental health professionals to assess an individual's cognitive, behavioral, and emotional status. The schedule typically covers areas such as orientation, attention, memory, language, visuospatial abilities, executive functions, and mood and affect. It is often used in research, clinical settings, and epidemiological studies to evaluate psychiatric and neurological conditions, as well as the effects of treatments or interventions. The specific version of the Mental Status Schedule may vary, but it generally includes a structured format with clear questions and response options to ensure standardization and reliability in the assessment process.

Retrograde amnesia is a form of memory loss where an individual cannot recall information, events, or facts from their personal past before a specific point in time. This type of amnesia is caused by damage to the brain, often as a result of head injury, stroke, infection, or certain medical conditions. The extent and duration of retrograde amnesia can vary widely, depending on the severity and location of the brain injury. In some cases, memory function may return over time as the brain heals, while in other cases the memory loss may be permanent.

Neurological diagnostic techniques are medical tests and examinations used to identify and diagnose conditions related to the nervous system, which includes the brain, spinal cord, nerves, and muscles. These techniques can be divided into several categories:

1. Clinical Examination: A thorough physical examination, including a neurological evaluation, is often the first step in diagnosing neurological conditions. This may involve assessing a person's mental status, muscle strength, coordination, reflexes, sensation, and gait.

2. Imaging Techniques: These are used to produce detailed images of the brain and nervous system. Common imaging techniques include:

- Computed Tomography (CT): This uses X-rays to create cross-sectional images of the brain and other parts of the body.
- Magnetic Resonance Imaging (MRI): This uses a strong magnetic field and radio waves to produce detailed images of the brain and other internal structures.
- Functional MRI (fMRI): This is a type of MRI that measures brain activity by detecting changes in blood flow.
- Positron Emission Tomography (PET): This uses small amounts of radioactive material to produce detailed images of brain function.
- Single Photon Emission Computed Tomography (SPECT): This is a type of nuclear medicine imaging that uses a gamma camera and a computer to produce detailed images of brain function.

3. Electrophysiological Tests: These are used to measure the electrical activity of the brain and nervous system. Common electrophysiological tests include:

- Electroencephalography (EEG): This measures the electrical activity of the brain.
- Evoked Potentials (EPs): These measure the electrical response of the brain and nervous system to sensory stimuli, such as sound or light.
- Nerve Conduction Studies (NCS): These measure the speed and strength of nerve impulses.
- Electromyography (EMG): This measures the electrical activity of muscles.

4. Laboratory Tests: These are used to analyze blood, cerebrospinal fluid, and other bodily fluids for signs of neurological conditions. Common laboratory tests include:

- Complete Blood Count (CBC): This measures the number and type of white and red blood cells in the body.
- Blood Chemistry Tests: These measure the levels of various chemicals in the blood.
- Lumbar Puncture (Spinal Tap): This is used to collect cerebrospinal fluid for analysis.
- Genetic Testing: This is used to identify genetic mutations associated with neurological conditions.

5. Imaging Studies: These are used to produce detailed images of the brain and nervous system. Common imaging studies include:

- Magnetic Resonance Imaging (MRI): This uses a strong magnetic field and radio waves to produce detailed images of the brain and nervous system.
- Computed Tomography (CT): This uses X-rays to produce detailed images of the brain and nervous system.
- Functional MRI (fMRI): This measures changes in blood flow in the brain during cognitive tasks.
- Diffusion Tensor Imaging (DTI): This is used to assess white matter integrity in the brain.
- Magnetic Resonance Spectroscopy (MRS): This is used to measure chemical levels in the brain.

Cognition refers to the mental processes involved in acquiring, processing, and utilizing information. These processes include perception, attention, memory, language, problem-solving, and decision-making. Cognitive functions allow us to interact with our environment, understand and respond to stimuli, learn new skills, and remember experiences.

In a medical context, cognitive function is often assessed as part of a neurological or psychiatric evaluation. Impairments in cognition can be caused by various factors, such as brain injury, neurodegenerative diseases (e.g., Alzheimer's disease), infections, toxins, and mental health conditions. Assessing cognitive function helps healthcare professionals diagnose conditions, monitor disease progression, and develop treatment plans.

Executive function is a term used to describe a set of cognitive processes that are necessary for the control and regulation of thought and behavior. These functions include:

1. Working memory: The ability to hold and manipulate information in mind over short periods of time.
2. Cognitive flexibility: The ability to switch between tasks or mental sets, and to adapt to new rules and situations.
3. Inhibitory control: The ability to inhibit or delay automatic responses, and to resist impulses and distractions.
4. Planning and organization: The ability to plan and organize actions, and to manage time and resources effectively.
5. Problem-solving: The ability to analyze problems, generate solutions, and evaluate the outcomes of actions.
6. Decision-making: The ability to weigh risks and benefits, and to make informed choices based on available information.
7. Emotional regulation: The ability to manage and regulate emotions, and to respond appropriately to social cues and situations.

Executive functions are primarily controlled by the frontal lobes of the brain, and they play a critical role in goal-directed behavior, problem-solving, decision-making, and self-regulation. Deficits in executive function can have significant impacts on daily life, including difficulties with academic performance, work productivity, social relationships, and mental health.

Memory disorders are a category of cognitive impairments that affect an individual's ability to acquire, store, retain, and retrieve memories. These disorders can be caused by various underlying medical conditions, including neurological disorders, psychiatric illnesses, substance abuse, or even normal aging processes. Some common memory disorders include:

1. Alzheimer's disease: A progressive neurodegenerative disorder that primarily affects older adults and is characterized by a decline in cognitive abilities, including memory, language, problem-solving, and decision-making skills.
2. Dementia: A broader term used to describe a group of symptoms associated with a decline in cognitive function severe enough to interfere with daily life. Alzheimer's disease is the most common cause of dementia, but other causes include vascular dementia, Lewy body dementia, and frontotemporal dementia.
3. Amnesia: A memory disorder characterized by difficulties in forming new memories or recalling previously learned information due to brain damage or disease. Amnesia can be temporary or permanent and may result from head trauma, stroke, infection, or substance abuse.
4. Mild cognitive impairment (MCI): A condition where an individual experiences mild but noticeable memory or cognitive difficulties that are greater than expected for their age and education level. While some individuals with MCI may progress to dementia, others may remain stable or even improve over time.
5. Korsakoff's syndrome: A memory disorder often caused by alcohol abuse and thiamine deficiency, characterized by severe short-term memory loss, confabulation (making up stories to fill in memory gaps), and disorientation.

It is essential to consult a healthcare professional if you or someone you know experiences persistent memory difficulties, as early diagnosis and intervention can help manage symptoms and improve quality of life.

I must clarify that the term "pedigree" is not typically used in medical definitions. Instead, it is often employed in genetics and breeding, where it refers to the recorded ancestry of an individual or a family, tracing the inheritance of specific traits or diseases. In human genetics, a pedigree can help illustrate the pattern of genetic inheritance in families over multiple generations. However, it is not a medical term with a specific clinical definition.

The cerebral cortex is the outermost layer of the brain, characterized by its intricate folded structure and wrinkled appearance. It is a region of great importance as it plays a key role in higher cognitive functions such as perception, consciousness, thought, memory, language, and attention. The cerebral cortex is divided into two hemispheres, each containing four lobes: the frontal, parietal, temporal, and occipital lobes. These areas are responsible for different functions, with some regions specializing in sensory processing while others are involved in motor control or associative functions. The cerebral cortex is composed of gray matter, which contains neuronal cell bodies, and is covered by a layer of white matter that consists mainly of myelinated nerve fibers.

The basal ganglia are a group of interconnected nuclei, or clusters of neurons, located in the base of the brain. They play a crucial role in regulating motor function, cognition, and emotion. The main components of the basal ganglia include the striatum (made up of the caudate nucleus, putamen, and ventral striatum), globus pallidus (divided into external and internal segments), subthalamic nucleus, and substantia nigra (with its pars compacta and pars reticulata).

The basal ganglia receive input from various regions of the cerebral cortex and other brain areas. They process this information and send output back to the thalamus and cortex, helping to modulate and coordinate movement. The basal ganglia also contribute to higher cognitive functions such as learning, decision-making, and habit formation. Dysfunction in the basal ganglia can lead to neurological disorders like Parkinson's disease, Huntington's disease, and dystonia.

Parkinson's disease is a progressive neurodegenerative disorder that affects movement. It is characterized by the death of dopamine-producing cells in the brain, specifically in an area called the substantia nigra. The loss of these cells leads to a decrease in dopamine levels, which results in the motor symptoms associated with Parkinson's disease. These symptoms can include tremors at rest, stiffness or rigidity of the limbs and trunk, bradykinesia (slowness of movement), and postural instability (impaired balance and coordination). In addition to these motor symptoms, non-motor symptoms such as cognitive impairment, depression, anxiety, and sleep disturbances are also common in people with Parkinson's disease. The exact cause of Parkinson's disease is unknown, but it is thought to be a combination of genetic and environmental factors. There is currently no cure for Parkinson's disease, but medications and therapies can help manage the symptoms and improve quality of life.

Aphasia is a medical condition that affects a person's ability to communicate. It is caused by damage to the language areas of the brain, most commonly as a result of a stroke or head injury. Aphasia can affect both spoken and written language, making it difficult for individuals to express their thoughts, understand speech, read, or write.

There are several types of aphasia, including:

1. Expressive aphasia (also called Broca's aphasia): This type of aphasia affects a person's ability to speak and write clearly. Individuals with expressive aphasia know what they want to say but have difficulty forming the words or sentences to communicate their thoughts.
2. Receptive aphasia (also called Wernicke's aphasia): This type of aphasia affects a person's ability to understand spoken or written language. Individuals with receptive aphasia may struggle to follow conversations, comprehend written texts, or make sense of the words they hear or read.
3. Global aphasia: This is the most severe form of aphasia and results from extensive damage to the language areas of the brain. People with global aphasia have significant impairments in both their ability to express themselves and understand language.
4. Anomic aphasia: This type of aphasia affects a person's ability to recall the names of objects, people, or places. Individuals with anomic aphasia can speak in complete sentences but often struggle to find the right words to convey their thoughts.

Treatment for aphasia typically involves speech and language therapy, which aims to help individuals regain as much communication ability as possible. The success of treatment depends on various factors, such as the severity and location of the brain injury, the individual's motivation and effort, and the availability of support from family members and caregivers.

Human chromosome pair 9 consists of two rod-shaped structures present in the nucleus of each cell of the human body. Each member of the pair contains thousands of genes and other genetic material, encoded in the form of DNA molecules. The two chromosomes in a pair are identical or very similar to each other in terms of their size, shape, and genetic makeup.

Chromosome 9 is one of the autosomal chromosomes, meaning that it is not a sex chromosome (X or Y) and is present in two copies in all cells of the body, regardless of sex. Chromosome 9 is a medium-sized chromosome, and it is estimated to contain around 135 million base pairs of DNA and approximately 1200 genes.

Chromosome 9 contains several important genes that are associated with various human traits and diseases. For example, mutations in the gene that encodes the protein APOE on chromosome 9 have been linked to an increased risk of developing Alzheimer's disease. Additionally, variations in the gene that encodes the protein EGFR on chromosome 9 have been associated with an increased risk of developing certain types of cancer.

Overall, human chromosome pair 9 plays a critical role in the development and function of the human body, and variations in its genetic makeup can contribute to a wide range of traits and diseases.

Neuroimaging is a medical term that refers to the use of various techniques to either directly or indirectly image the structure, function, or pharmacology of the nervous system. It includes techniques such as computed tomography (CT), magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and diffusion tensor imaging (DTI). These techniques are used to diagnose and monitor various neurological and psychiatric conditions, as well as to understand the underlying mechanisms of brain function in health and disease.

Language disorders, also known as communication disorders, refer to a group of conditions that affect an individual's ability to understand or produce spoken, written, or other symbolic language. These disorders can be receptive (difficulty understanding language), expressive (difficulty producing language), or mixed (a combination of both).

Language disorders can manifest as difficulties with grammar, vocabulary, sentence structure, and coherence in communication. They can also affect social communication skills such as taking turns in conversation, understanding nonverbal cues, and interpreting tone of voice.

Language disorders can be developmental, meaning they are present from birth or early childhood, or acquired, meaning they develop later in life due to injury, illness, or trauma. Examples of acquired language disorders include aphasia, which can result from stroke or brain injury, and dysarthria, which can result from neurological conditions affecting speech muscles.

Language disorders can have significant impacts on an individual's academic, social, and vocational functioning, making it important to diagnose and treat them as early as possible. Treatment typically involves speech-language therapy to help individuals develop and improve their language skills.

Multi-infarct dementia (MID) is a specific type of dementia that is caused by multiple small strokes or mini-strokes (known as transient ischemic attacks or TIAs) in the brain. Also known as vascular dementia, multi-infarct dementia results from the interruption of blood flow to parts of the brain, leading to damage and death of brain tissue.

The term 'multi-infarct' refers to multiple areas (or infarcts) of damaged or dead tissue in the brain due to the lack of oxygen and nutrients caused by these small strokes. Over time, as more areas of the brain are affected, cognitive decline becomes apparent, leading to symptoms such as memory loss, difficulty with problem-solving, disorientation, language problems, and changes in mood or behavior.

Multi-infarct dementia is typically a progressive condition, meaning that symptoms worsen over time. However, the rate of progression can vary depending on factors such as the number and severity of strokes, underlying medical conditions, and lifestyle factors. It's important to note that multi-infarct dementia can be prevented or delayed by controlling risk factors for stroke, such as high blood pressure, diabetes, smoking, and high cholesterol.

A caregiver is an individual who provides assistance and support to another person who is unable to meet their own needs for activities of daily living due to illness, disability, frailty, or other reasons. Caregiving can take many forms, including providing physical care, emotional support, managing medications, assisting with mobility, and helping with household tasks and errands. Caregivers may be family members, friends, or professional providers, and the level of care they provide can range from a few hours a week to round-the-clock assistance. In medical contexts, caregivers are often referred to as informal or family caregivers when they are unpaid relatives or friends, and professional or paid caregivers when they are hired to provide care.

Ubiquitin is a small protein that is present in all eukaryotic cells and plays a crucial role in the regulation of various cellular processes, such as protein degradation, DNA repair, and stress response. It is involved in marking proteins for destruction by attaching to them, a process known as ubiquitination. This modification can target proteins for degradation by the proteasome, a large protein complex that breaks down unneeded or damaged proteins in the cell. Ubiquitin also has other functions, such as regulating the localization and activity of certain proteins. The ability of ubiquitin to modify many different proteins and play a role in multiple cellular processes makes it an essential player in maintaining cellular homeostasis.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

DNA-binding proteins are a type of protein that have the ability to bind to DNA (deoxyribonucleic acid), the genetic material of organisms. These proteins play crucial roles in various biological processes, such as regulation of gene expression, DNA replication, repair and recombination.

The binding of DNA-binding proteins to specific DNA sequences is mediated by non-covalent interactions, including electrostatic, hydrogen bonding, and van der Waals forces. The specificity of binding is determined by the recognition of particular nucleotide sequences or structural features of the DNA molecule.

DNA-binding proteins can be classified into several categories based on their structure and function, such as transcription factors, histones, and restriction enzymes. Transcription factors are a major class of DNA-binding proteins that regulate gene expression by binding to specific DNA sequences in the promoter region of genes and recruiting other proteins to modulate transcription. Histones are DNA-binding proteins that package DNA into nucleosomes, the basic unit of chromatin structure. Restriction enzymes are DNA-binding proteins that recognize and cleave specific DNA sequences, and are widely used in molecular biology research and biotechnology applications.

Neurology is a branch of medicine that deals with the study and treatment of diseases and disorders of the nervous system, which includes the brain, spinal cord, peripheral nerves, muscles, and autonomic nervous system. Neurologists are medical doctors who specialize in this field, diagnosing and treating conditions such as stroke, Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, and various types of headaches and pain disorders. They use a variety of diagnostic tests, including imaging studies like MRI and CT scans, electrophysiological tests like EEG and EMG, and laboratory tests to evaluate nerve function and identify any underlying conditions or abnormalities. Treatment options may include medication, surgery, rehabilitation, or lifestyle modifications.

Endosomal Sorting Complexes Required for Transport (ESCRT) are a set of protein complexes found in the endosomal membrane of eukaryotic cells. They play a crucial role in the sorting and trafficking of proteins and lipids between various cellular compartments, particularly in the formation of vesicles and the budding of viruses.

The ESCRT system is composed of several distinct complexes (ESCRT-0, -I, -II, and -III) that work together in a coordinated manner to carry out their functions. ESCRT-0 recognizes and binds to ubiquitinated proteins on the endosomal membrane, initiating the sorting process. ESCRT-I and -II then help to deform the membrane and recruit ESCRT-III, which forms a tight spiral around the neck of the budding vesicle. Finally, the AAA+ ATPase Vps4 disassembles the ESCRT-III complex, allowing for the release of the vesicle into the lumen of the endosome or extracellular space.

Defects in the ESCRT system have been linked to a variety of human diseases, including neurological disorders, cancer, and viral infections.

Emission-Computed Tomography, Single-Photon (SPECT) is a type of nuclear medicine imaging procedure that generates detailed, three-dimensional images of the distribution of radioactive pharmaceuticals within the body. It uses gamma rays emitted by a radiopharmaceutical that is introduced into the patient's body, and a specialized gamma camera to detect these gamma rays and create tomographic images. The data obtained from the SPECT imaging can be used to diagnose various medical conditions, evaluate organ function, and guide treatment decisions. It is commonly used to image the heart, brain, and bones, among other organs and systems.

Social behavior, in the context of medicine and psychology, refers to the ways in which individuals interact and engage with others within their social environment. It involves various actions, communications, and responses that are influenced by cultural norms, personal values, emotional states, and cognitive processes. These behaviors can include but are not limited to communication, cooperation, competition, empathy, altruism, aggression, and conformity.

Abnormalities in social behavior may indicate underlying mental health conditions such as autism spectrum disorder, schizophrenia, or personality disorders. Therefore, understanding and analyzing social behavior is an essential aspect of diagnosing and treating various psychological and psychiatric conditions.

Gliosis is a term used in histopathology and neuroscience to describe the reaction of support cells in the brain, called glial cells, to injury or disease. This response includes an increase in the number and size of glial cells, as well as changes in their shape and function. The most common types of glial cells involved in gliosis are astrocytes and microglia.

Gliosis can be triggered by a variety of factors, including trauma, infection, inflammation, neurodegenerative diseases, and stroke. In response to injury or disease, astrocytes become hypertrophied (enlarged) and undergo changes in their gene expression profile that can lead to the production of various proteins, such as glial fibrillary acidic protein (GFAP). These changes can result in the formation of a dense network of astrocytic processes, which can contribute to the formation of a glial scar.

Microglia, another type of glial cell, become activated during gliosis and play a role in the immune response in the central nervous system (CNS). They can release pro-inflammatory cytokines, chemokines, and reactive oxygen species that contribute to the inflammatory response.

While gliosis is a protective response aimed at containing damage and promoting tissue repair, it can also have negative consequences. For example, the formation of glial scars can impede axonal regeneration and contribute to neurological deficits. Additionally, chronic activation of microglia has been implicated in various neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Nerve degeneration, also known as neurodegeneration, is the progressive loss of structure and function of neurons, which can lead to cognitive decline, motor impairment, and various other symptoms. This process occurs due to a variety of factors, including genetics, environmental influences, and aging. It is a key feature in several neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple sclerosis. The degeneration can affect any part of the nervous system, leading to different symptoms depending on the location and extent of the damage.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

An "atlas" in the medical context refers to a collection of anatomical plates or illustrations, often accompanied by detailed descriptions or explanations. A medical atlas is a type of textbook that focuses primarily on providing visual representations of human anatomy, physiology, or pathology. These atlases are used by medical students, healthcare professionals, and researchers to learn about the structure and function of the human body, as well as to identify and understand various diseases and conditions.

Medical atlases can cover a wide range of topics, including gross anatomy, histology (the study of tissues), embryology (the study of embryonic development), pathology (the study of disease), and radiology (the use of medical imaging to diagnose and treat diseases). Some atlases may focus on specific regions or systems of the body, such as the nervous system, musculoskeletal system, or cardiovascular system.

Medical atlases are often used in conjunction with other educational materials, such as textbooks, lectures, and hands-on dissections. They can be a valuable resource for students and practitioners seeking to deepen their understanding of human anatomy and related fields.

AIDS Dementia Complex (ADC) is a neurological disorder that occurs in people with advanced HIV infection or AIDS. It is also known as HIV-associated dementia (HAD) or HIV encephalopathy. ADC is characterized by cognitive impairment, motor dysfunction, and behavioral changes that can significantly affect the individual's daily functioning and quality of life.

The symptoms of AIDS Dementia Complex may include:
- Difficulty with concentration and memory
- Slowness in thinking, processing information, or making decisions
- Changes in mood or personality, such as depression, irritability, or apathy
- Difficulty with coordination, balance, or speech
- Progressive weakness and wasting of muscles
- Difficulty with swallowing or speaking

The exact cause of ADC is not fully understood, but it is believed to be related to the direct effects of HIV on the brain. The virus can infect and damage nerve cells, leading to inflammation and degeneration of brain tissue. Treatment for ADC typically involves antiretroviral therapy (ART) to control HIV replication, as well as medications to manage specific symptoms. In some cases, supportive care such as physical therapy or occupational therapy may also be recommended.

Proteins are complex, large molecules that play critical roles in the body's functions. They are made up of amino acids, which are organic compounds that are the building blocks of proteins. Proteins are required for the structure, function, and regulation of the body's tissues and organs. They are essential for the growth, repair, and maintenance of body tissues, and they play a crucial role in many biological processes, including metabolism, immune response, and cellular signaling. Proteins can be classified into different types based on their structure and function, such as enzymes, hormones, antibodies, and structural proteins. They are found in various foods, especially animal-derived products like meat, dairy, and eggs, as well as plant-based sources like beans, nuts, and grains.

Functional laterality, in a medical context, refers to the preferential use or performance of one side of the body over the other for specific functions. This is often demonstrated in hand dominance, where an individual may be right-handed or left-handed, meaning they primarily use their right or left hand for tasks such as writing, eating, or throwing.

However, functional laterality can also apply to other bodily functions and structures, including the eyes (ocular dominance), ears (auditory dominance), or legs. It's important to note that functional laterality is not a strict binary concept; some individuals may exhibit mixed dominance or no strong preference for one side over the other.

In clinical settings, assessing functional laterality can be useful in diagnosing and treating various neurological conditions, such as stroke or traumatic brain injury, where understanding any resulting lateralized impairments can inform rehabilitation strategies.

Positron-Emission Tomography (PET) is a type of nuclear medicine imaging that uses small amounts of radioactive material, called a radiotracer, to produce detailed, three-dimensional images. This technique measures metabolic activity within the body, such as sugar metabolism, to help distinguish between healthy and diseased tissue, identify cancerous cells, or examine the function of organs.

During a PET scan, the patient is injected with a radiotracer, typically a sugar-based compound labeled with a positron-emitting radioisotope, such as fluorine-18 (^18^F). The radiotracer accumulates in cells that are metabolically active, like cancer cells. As the radiotracer decays, it emits positrons, which then collide with electrons in nearby tissue, producing gamma rays. A special camera, called a PET scanner, detects these gamma rays and uses this information to create detailed images of the body's internal structures and processes.

PET is often used in conjunction with computed tomography (CT) or magnetic resonance imaging (MRI) to provide both functional and anatomical information, allowing for more accurate diagnosis and treatment planning. Common applications include detecting cancer recurrence, staging and monitoring cancer, evaluating heart function, and assessing brain function in conditions like dementia and epilepsy.

Apolipoprotein E (APOE) is a gene that provides instructions for making a protein involved in the metabolism of fats called lipids. One variant of this gene, APOE4, is associated with an increased risk of developing Alzheimer's disease and other forms of dementia.

The APOE4 allele (variant) is less efficient at clearing beta-amyloid protein, a component of the amyloid plaques found in the brains of people with Alzheimer's disease. This can lead to an accumulation of beta-amyloid and an increased risk of developing Alzheimer's disease.

It is important to note that having one or two copies of the APOE4 allele does not mean that a person will definitely develop Alzheimer's disease, but it does increase the risk. Other factors, such as age, family history, and the presence of other genetic variants, also contribute to the development of this complex disorder.

A language test is not a medical term per se, but it is commonly used in the field of speech-language pathology, which is a medical discipline. A language test, in this context, refers to an assessment tool used by speech-language pathologists to evaluate an individual's language abilities. These tests typically measure various aspects of language, including vocabulary, grammar, syntax, semantics, and pragmatics.

Language tests can be standardized or non-standardized and may be administered individually or in a group setting. The results of these tests help speech-language pathologists diagnose language disorders, develop treatment plans, and monitor progress over time. It is important to note that language testing should be conducted by a qualified professional who has experience in administering and interpreting language assessments.

Brain mapping is a broad term that refers to the techniques used to understand the structure and function of the brain. It involves creating maps of the various cognitive, emotional, and behavioral processes in the brain by correlating these processes with physical locations or activities within the nervous system. Brain mapping can be accomplished through a variety of methods, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scans, electroencephalography (EEG), and others. These techniques allow researchers to observe which areas of the brain are active during different tasks or thoughts, helping to shed light on how the brain processes information and contributes to our experiences and behaviors. Brain mapping is an important area of research in neuroscience, with potential applications in the diagnosis and treatment of neurological and psychiatric disorders.

Psychiatric Status Rating Scales are standardized assessment tools used by mental health professionals to evaluate and rate the severity of a person's psychiatric symptoms and functioning. These scales provide a systematic and structured approach to measuring various aspects of an individual's mental health, such as mood, anxiety, psychosis, behavior, and cognitive abilities.

The purpose of using Psychiatric Status Rating Scales is to:

1. Assess the severity and improvement of psychiatric symptoms over time.
2. Aid in diagnostic decision-making and treatment planning.
3. Monitor treatment response and adjust interventions accordingly.
4. Facilitate communication among mental health professionals about a patient's status.
5. Provide an objective basis for research and epidemiological studies.

Examples of Psychiatric Status Rating Scales include:

1. Clinical Global Impression (CGI): A brief, subjective rating scale that measures overall illness severity, treatment response, and improvement.
2. Positive and Negative Syndrome Scale (PANSS): A comprehensive scale used to assess the symptoms of psychosis, including positive, negative, and general psychopathology domains.
3. Hamilton Rating Scale for Depression (HRSD) or Montgomery-Åsberg Depression Rating Scale (MADRS): Scales used to evaluate the severity of depressive symptoms.
4. Young Mania Rating Scale (YMRS): A scale used to assess the severity of manic or hypomanic symptoms.
5. Brief Psychiatric Rating Scale (BPRS) or Symptom Checklist-90 Revised (SCL-90-R): Scales that measure a broad range of psychiatric symptoms and psychopathology.
6. Global Assessment of Functioning (GAF): A scale used to rate an individual's overall psychological, social, and occupational functioning on a hypothetical continuum of mental health-illness.

It is important to note that Psychiatric Status Rating Scales should be administered by trained mental health professionals to ensure accurate and reliable results.

A missense mutation is a type of point mutation in which a single nucleotide change results in the substitution of a different amino acid in the protein that is encoded by the affected gene. This occurs when the altered codon (a sequence of three nucleotides that corresponds to a specific amino acid) specifies a different amino acid than the original one. The function and/or stability of the resulting protein may be affected, depending on the type and location of the missense mutation. Missense mutations can have various effects, ranging from benign to severe, depending on the importance of the changed amino acid for the protein's structure or function.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Exons are the coding regions of DNA that remain in the mature, processed mRNA after the removal of non-coding intronic sequences during RNA splicing. These exons contain the information necessary to encode proteins, as they specify the sequence of amino acids within a polypeptide chain. The arrangement and order of exons can vary between different genes and even between different versions of the same gene (alternative splicing), allowing for the generation of multiple protein isoforms from a single gene. This complexity in exon structure and usage significantly contributes to the diversity and functionality of the proteome.

Diffusion Tensor Imaging (DTI) is a type of magnetic resonance imaging (MRI) technique that allows for the measurement and visualization of water diffusion in biological tissues, particularly in the brain. DTI provides information about the microstructural organization and integrity of nerve fibers within the brain by measuring the directionality of water diffusion in the brain's white matter tracts.

In DTI, a tensor is used to describe the three-dimensional diffusion properties of water molecules in each voxel (three-dimensional pixel) of an MRI image. The tensor provides information about the magnitude and direction of water diffusion, which can be used to calculate various diffusion metrics such as fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). These metrics provide insights into the structural properties of nerve fibers, including their orientation, density, and integrity.

DTI has numerous clinical applications, such as in the diagnosis and monitoring of neurological disorders like multiple sclerosis, traumatic brain injury, and neurodegenerative diseases. It can also be used for presurgical planning to identify critical white matter tracts that need to be preserved during surgery.

Emotions are complex psychological states that involve three distinct components: a subjective experience, a physiological response, and a behavioral or expressive response. Emotions can be short-lived, such as a flash of anger, or more long-lasting, such as enduring sadness. They can also vary in intensity, from mild irritation to intense joy or fear.

Emotions are often distinguished from other psychological states, such as moods and temperament, which may be less specific and more enduring. Emotions are typically thought to have a clear cause or object, such as feeling happy when you receive good news or feeling anxious before a job interview.

There are many different emotions that people can experience, including happiness, sadness, anger, fear, surprise, disgust, and shame. These emotions are often thought to serve important adaptive functions, helping individuals respond to challenges and opportunities in their environment.

In medical contexts, emotions may be relevant to the diagnosis and treatment of various mental health conditions, such as depression, anxiety disorders, and bipolar disorder. Abnormalities in emotional processing and regulation have been implicated in many psychiatric illnesses, and therapies that target these processes may be effective in treating these conditions.

The parietal lobe is a region of the brain that is located in the posterior part of the cerebral cortex, covering the upper and rear portions of the brain. It is involved in processing sensory information from the body, such as touch, temperature, and pain, as well as spatial awareness and perception, visual-spatial cognition, and the integration of different senses.

The parietal lobe can be divided into several functional areas, including the primary somatosensory cortex (which receives tactile information from the body), the secondary somatosensory cortex (which processes more complex tactile information), and the posterior parietal cortex (which is involved in spatial attention, perception, and motor planning).

Damage to the parietal lobe can result in various neurological symptoms, such as neglect of one side of the body, difficulty with spatial orientation, problems with hand-eye coordination, and impaired mathematical and language abilities.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

The hippocampus is a complex, curved formation in the brain that resembles a seahorse (hence its name, from the Greek word "hippos" meaning horse and "kampos" meaning sea monster). It's part of the limbic system and plays crucial roles in the formation of memories, particularly long-term ones.

This region is involved in spatial navigation and cognitive maps, allowing us to recognize locations and remember how to get to them. Additionally, it's one of the first areas affected by Alzheimer's disease, which often results in memory loss as an early symptom.

Anatomically, it consists of two main parts: the Ammon's horn (or cornu ammonis) and the dentate gyrus. These structures are made up of distinct types of neurons that contribute to different aspects of learning and memory.

The gyrus cinguli, also known as the cingulate gyrus, is a structure located in the brain. It forms part of the limbic system and plays a role in various functions such as emotion, memory, and perception of pain. The gyrus cinguli is situated in the medial aspect of the cerebral hemisphere, adjacent to the corpus callosum, and curves around the frontal portion of the corpus callosum, forming a C-shaped structure. It has been implicated in several neurological and psychiatric conditions, including depression, anxiety disorders, and chronic pain syndromes.

Adenosine triphosphatases (ATPases) are a group of enzymes that catalyze the conversion of adenosine triphosphate (ATP) into adenosine diphosphate (ADP) and inorganic phosphate. This reaction releases energy, which is used to drive various cellular processes such as muscle contraction, transport of ions across membranes, and synthesis of proteins and nucleic acids.

ATPases are classified into several types based on their structure, function, and mechanism of action. Some examples include:

1. P-type ATPases: These ATPases form a phosphorylated intermediate during the reaction cycle and are involved in the transport of ions across membranes, such as the sodium-potassium pump and calcium pumps.
2. F-type ATPases: These ATPases are found in mitochondria, chloroplasts, and bacteria, and are responsible for generating a proton gradient across the membrane, which is used to synthesize ATP.
3. V-type ATPases: These ATPases are found in vacuolar membranes and endomembranes, and are involved in acidification of intracellular compartments.
4. A-type ATPases: These ATPases are found in the plasma membrane and are involved in various functions such as cell signaling and ion transport.

Overall, ATPases play a crucial role in maintaining the energy balance of cells and regulating various physiological processes.

I'm sorry for any confusion, but "semantics" is not a term that has a specific medical definition. Semantics is actually a branch of linguistics that deals with the study of meaning, reference, and the interpretation of signs and symbols, either individually or in combination. It is used in various fields including computer science, anthropology, psychology, and philosophy.

However, if you have any medical terms or concepts that you would like me to explain, I'd be happy to help!

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Genetic predisposition to disease refers to an increased susceptibility or vulnerability to develop a particular illness or condition due to inheriting specific genetic variations or mutations from one's parents. These genetic factors can make it more likely for an individual to develop a certain disease, but it does not guarantee that the person will definitely get the disease. Environmental factors, lifestyle choices, and interactions between genes also play crucial roles in determining if a genetically predisposed person will actually develop the disease. It is essential to understand that having a genetic predisposition only implies a higher risk, not an inevitable outcome.

In the context of medicine, particularly in neurolinguistics and speech-language pathology, language is defined as a complex system of communication that involves the use of symbols (such as words, signs, or gestures) to express and exchange information. It includes various components such as phonology (sound systems), morphology (word structures), syntax (sentence structure), semantics (meaning), and pragmatics (social rules of use). Language allows individuals to convey their thoughts, feelings, and intentions, and to understand the communication of others. Disorders of language can result from damage to specific areas of the brain, leading to impairments in comprehension, production, or both.

"History, 19th Century" is not a medical term or concept. It refers to the historical events, developments, and figures related to the 1800s in various fields, including politics, culture, science, and technology. However, if you are looking for medical advancements during the 19th century, here's a brief overview:

The 19th century was a period of significant progress in medicine, with numerous discoveries and innovations that shaped modern medical practices. Some notable developments include:

1. Edward Jenner's smallpox vaccine (1796): Although not strictly within the 19th century, Jenner's discovery laid the foundation for vaccination as a preventive measure against infectious diseases.
2. Germ theory of disease: The work of Louis Pasteur, Robert Koch, and others established that many diseases were caused by microorganisms, leading to the development of antiseptic practices and vaccines.
3. Anesthesia: In 1842, Crawford Long first used ether as an anesthetic during surgery, followed by the introduction of chloroform in 1847 by James Simpson.
4. Antisepsis and asepsis: Joseph Lister introduced antiseptic practices in surgery, significantly reducing postoperative infections. Later, the concept of asepsis (sterilization) was developed to prevent contamination during surgical procedures.
5. Microbiology: The development of techniques for culturing and staining bacteria allowed for better understanding and identification of pathogens.
6. Physiology: Claude Bernard's work on the regulation of internal body functions, or homeostasis, contributed significantly to our understanding of human physiology.
7. Neurology: Jean-Martin Charcot made significant contributions to the study of neurological disorders, including multiple sclerosis and Parkinson's disease.
8. Psychiatry: Sigmund Freud developed psychoanalysis, a new approach to understanding mental illnesses.
9. Public health: The 19th century saw the establishment of public health organizations and initiatives aimed at improving sanitation, water quality, and vaccination programs.
10. Medical education reforms: The Flexner Report in 1910 led to significant improvements in medical education standards and practices.

A facial expression is a result of the contraction or relaxation of muscles in the face that change the physical appearance of an individual's face to convey various emotions, intentions, or physical sensations. Facial expressions can be voluntary or involuntary and are a form of non-verbal communication that plays a crucial role in social interaction and conveying a person's state of mind.

The seven basic facial expressions of emotion, as proposed by Paul Ekman, include happiness, sadness, fear, disgust, surprise, anger, and contempt. These facial expressions are universally recognized across cultures and can be detected through the interpretation of specific muscle movements in the face, known as action units, which are measured and analyzed in fields such as psychology, neurology, and computer vision.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

In the context of medical and clinical psychology, particularly in the field of applied behavior analysis (ABA), "verbal behavior" is a term used to describe the various functions or purposes of spoken language. It was first introduced by the psychologist B.F. Skinner in his 1957 book "Verbal Behavior."

Skinner proposed that verbal behavior could be classified into several categories based on its function, including:

1. Mand: A verbal operant in which a person requests or demands something from another person. For example, saying "I would like a glass of water" is a mand.
2. Tact: A verbal operant in which a person describes or labels something in their environment. For example, saying "That's a red apple" is a tact.
3. Echoic: A verbal operant in which a person repeats or imitates what they have heard. For example, saying "Hello" after someone says hello to you is an echoic.
4. Intraverbal: A verbal operant in which a person responds to another person's verbal behavior with their own verbal behavior, without simply repeating or imitating what they have heard. For example, answering a question like "What's the capital of France?" is an intraverbal.
5. Textual: A verbal operant in which a person reads or writes text. For example, reading a book or writing a letter are textual.

Understanding the function of verbal behavior can be helpful in assessing and treating communication disorders, such as those seen in autism spectrum disorder (ASD). By identifying the specific functions of a child's verbal behavior, therapists can develop targeted interventions to help them communicate more effectively.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Genetic linkage is the phenomenon where two or more genetic loci (locations on a chromosome) tend to be inherited together because they are close to each other on the same chromosome. This occurs during the process of sexual reproduction, where homologous chromosomes pair up and exchange genetic material through a process called crossing over.

The closer two loci are to each other on a chromosome, the lower the probability that they will be separated by a crossover event. As a result, they are more likely to be inherited together and are said to be linked. The degree of linkage between two loci can be measured by their recombination frequency, which is the percentage of meiotic events in which a crossover occurs between them.

Linkage analysis is an important tool in genetic research, as it allows researchers to identify and map genes that are associated with specific traits or diseases. By analyzing patterns of linkage between markers (identifiable DNA sequences) and phenotypes (observable traits), researchers can infer the location of genes that contribute to those traits or diseases on chromosomes.

Broca's aphasia, also known as expressive aphasia or nonfluent aphasia, is a type of language disorder that results from damage to the brain's Broca's area, which is located in the frontal lobe of the dominant hemisphere (usually the left).

Individuals with Broca's aphasia have difficulty producing spoken or written language. They often know what they want to say but have trouble getting the words out, resulting in short and grammatically simplified sentences. Speech may be slow, laborious, and agrammatic, with limited vocabulary and poor sentence structure. Comprehension of language is typically less affected than expression, although individuals with Broca's aphasia may have difficulty understanding complex grammatical structures or following rapid speech.

It's important to note that the severity and specific symptoms of Broca's aphasia can vary depending on the extent and location of the brain damage. Rehabilitation and therapy can help improve language skills in individuals with Broca's aphasia, although recovery may be slow and limited.

Comprehension, in a medical context, usually refers to the ability to understand and interpret spoken or written language, as well as gestures and expressions. It is a key component of communication and cognitive functioning. Difficulties with comprehension can be a symptom of various neurological conditions, such as aphasia (a disorder caused by damage to the language areas of the brain), learning disabilities, or dementia. Assessment of comprehension is often part of neuropsychological evaluations and speech-language pathology assessments.

A syndrome, in medical terms, is a set of symptoms that collectively indicate or characterize a disease, disorder, or underlying pathological process. It's essentially a collection of signs and/or symptoms that frequently occur together and can suggest a particular cause or condition, even though the exact physiological mechanisms might not be fully understood.

For example, Down syndrome is characterized by specific physical features, cognitive delays, and other developmental issues resulting from an extra copy of chromosome 21. Similarly, metabolic syndromes like diabetes mellitus type 2 involve a group of risk factors such as obesity, high blood pressure, high blood sugar, and abnormal cholesterol or triglyceride levels that collectively increase the risk of heart disease, stroke, and diabetes.

It's important to note that a syndrome is not a specific diagnosis; rather, it's a pattern of symptoms that can help guide further diagnostic evaluation and management.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Discriminant analysis is a statistical method used for classifying observations or individuals into distinct categories or groups based on multiple predictor variables. It is commonly used in medical research to help diagnose or predict the presence or absence of a particular condition or disease.

In discriminant analysis, a linear combination of the predictor variables is created, and the resulting function is used to determine the group membership of each observation. The function is derived from the means and variances of the predictor variables for each group, with the goal of maximizing the separation between the groups while minimizing the overlap.

There are two types of discriminant analysis:

1. Linear Discriminant Analysis (LDA): This method assumes that the predictor variables are normally distributed and have equal variances within each group. LDA is used when there are two or more groups to be distinguished.
2. Quadratic Discriminant Analysis (QDA): This method does not assume equal variances within each group, allowing for more flexibility in modeling the distribution of predictor variables. QDA is used when there are two or more groups to be distinguished.

Discriminant analysis can be useful in medical research for developing diagnostic models that can accurately classify patients based on a set of clinical or laboratory measures. It can also be used to identify which predictor variables are most important in distinguishing between different groups, providing insights into the underlying biological mechanisms of disease.

The occipital lobe is the portion of the cerebral cortex that lies at the back of the brain (posteriorly) and is primarily involved in visual processing. It contains areas that are responsible for the interpretation and integration of visual stimuli, including color, form, movement, and recognition of objects. The occipital lobe is divided into several regions, such as the primary visual cortex (V1), secondary visual cortex (V2 to V5), and the visual association cortex, which work together to process different aspects of visual information. Damage to the occipital lobe can lead to various visual deficits, including blindness or partial loss of vision, known as a visual field cut.

A nerve net, also known as a neural net or neuronal network, is not a medical term per se, but rather a concept in neuroscience and artificial intelligence (AI). It refers to a complex network of interconnected neurons that process and transmit information. In the context of the human body, the nervous system can be thought of as a type of nerve net, with the brain and spinal cord serving as the central processing unit and peripheral nerves carrying signals to and from various parts of the body.

In the field of AI, artificial neural networks are computational models inspired by the structure and function of biological nerve nets. These models consist of interconnected nodes or "neurons" that process information and learn patterns through a process of training and adaptation. They have been used in a variety of applications, including image recognition, natural language processing, and machine learning.

Cross-sectional anatomy refers to the study and visualization of the internal structures of the body as if they were cut along a plane, creating a two-dimensional image. This method allows for a detailed examination of the relationships between various organs, tissues, and structures that may not be as easily appreciated through traditional observation or examination.

In cross-sectional anatomy, different imaging techniques such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and ultrasound are used to create detailed images of the body's internal structures at various depths and planes. These images can help medical professionals diagnose conditions, plan treatments, and assess the effectiveness of interventions.

Cross-sectional anatomy is an important tool in modern medicine, as it provides a more comprehensive understanding of the human body than traditional gross anatomy alone. By allowing for a detailed examination of the internal structures of the body, cross-sectional anatomy can help medical professionals make more informed decisions about patient care.

"What is frontotemporal dementia". Dementia UK. Retrieved 2020-10-19. Finger, EC (April 2016). "Frontotemporal Dementias". ... Frontotemporal dementia (FTD), or frontotemporal degeneration disease, or frontotemporal neurocognitive disorder, encompasses ... Frontotemporal dementias are mostly early-onset syndromes that are linked to frontotemporal lobar degeneration (FTLD), which is ... The main subtypes of frontotemporal dementia are behavioral variant FTD, semantic dementia, progressive nonfluent aphasia, and ...
... (FTDP-17) is an autosomal dominant neurodegenerative tauopathy ...
Amyotrophic lateral sclerosis Creutzfeldt-Jakob disease Frontotemporal Dementia Dementia with Lewy bodies Corticobasal ... Snowden JS, Neary D, Mann DM; Neary; Mann (February 2002). "Frontotemporal dementia". Br J Psychiatry. 180 (2): 140-3. doi: ... Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N (2010). "Caffeine intake and dementia: systematic review and meta-analysis ... Consumption of fruits, fish and vegetables confer protection against dementia, as does a Mediterranean diet. Physical exercise ...
Farese is a co-founder and board member of the Bluefield Project to Cure Frontotemporal Dementia (FTD) Research. His work has ... "Mission of The Bluefield Project to Cure FTD , Frontotemporal dementia". www.bluefieldproject.org. Retrieved 2022-10-07. "Board ... "Protein Deficiency in Brain Plays Key Role in Early-Onset Dementia , UC San Francisco". www.ucsf.edu. Retrieved 2022-10-07. ( ...
Frontotemporal dementia. Showed a protein called progranulin prevents a type of brain cells from becoming "hyperactive". If not ... "Gladstone scientists identify role of key protein in ALS and frontotemporal dementia" (Press release). January 12, 2010. ... frontotemporal dementia (FTD), Huntington's disease, amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) and multiple ... "Studies tie abnormal protein build-up to dementia". The New York Times. " ...
Other common causes include vascular dementia, dementia with Lewy bodies, frontotemporal dementia, and mixed dementia (commonly ... causing HIV dementia; frontotemporal lobar degeneration for frontotemporal dementia; or Lewy body disease for dementia with ... In some types of dementia, such as dementia with Lewy bodies and frontotemporal dementia, personality changes and difficulty ... vascular dementia, and frontotemporal dementia. A strict gluten-free diet started early may protect against dementia associated ...
Warren, JD; Rohrer, JD; Rossor, MN (2013-08-06). "Frontotemporal dementia". The BMJ. 347: f4827. doi:10.1136/bmj.f4827. ISSN ... Ehlers-Danlos syndrome Fibrodysplasia ossificans progressiva Friedreich's ataxia Frontotemporal dementia (FTD) Some ... Korczyn, AD; Vakhapova, V; Grinberg, LT (2012-11-15). "Vascular dementia". Journal of the Neurological Sciences. 322 (1-2): 2- ... but often appears alongside other forms of degenerative dementia) Life extension Senescence Progressive disease List of genetic ...
Frontotemporal Dementia. Cambridge University Press. ISBN 9781107086630. Mesulam MM (2003). "Primary progressive aphasia-a ... Nov 2006). "Semantic dementia and fluent primary progressive aphasia: two sides of the same coin?". Brain. 129 (Pt 11): 3066-80 ... However, relatives of a person with any form of frontotemporal lobar degeneration, including PPA, are at slightly greater risk ... Rapid and sustained improvement in speech and dementia in a patient with primary progressive aphasia utilizing off-label ...
So far it has only been tested in mice with frontotemporal dementia but Alzheimer's Society is now funding the researchers to ... "Frontotemporal dementia - NHS Choices". www.nhs.uk. Retrieved 2017-06-14. Publications by Giovanna Mallucci at ResearchGate ( ... Testing on mice with prion disease and a form of familial tauopathy or frontotemporal dementia (FTD) identified two drugs that ... "The drug blocks a natural defense mechanism in cells which is overactive in the brains of people with frontotemporal dementia, ...
"Alzheimer Europe - Dementia - Other forms of dementia - Neurodegenerative diseases - Fronto-Temporal Degeneration - Semantic ... "Alzheimer Europe - Dementia - Other forms of dementia - Neurodegenerative diseases - Fronto-Temporal Degeneration - Semantic ... semantic dementia can be regionally dissociated from the other subtypes of frontotemporal lobar degeneration, frontotemporal ... Weder ND, Aziz R, Wilkins K, Tampi RR (2007). "Frontotemporal dementias: a review". Ann Gen Psychiatry. 6: 15. doi:10.1186/1744 ...
Finger EC (April 2016). "Frontotemporal Dementias". Continuum (Review). 22 (2 Dementia): 464-89. doi:10.1212/CON. ... Frontotemporal dementia (Pick's disease) Gerstmann-Sträussler-Scheinker syndrome Huntington's disease Lytico-bodig disease (ALS ... These are the four motor symptoms found in Parkinson's disease (PD) - after which it is named - dementia with Lewy bodies (DLB ... July 2017). "Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium". Neurology ( ...
Finger EC (April 2016). "Frontotemporal Dementias". Continuum (Minneap Minn) (Review). 22 (2 Dementia): 464-89. doi:10.1212/CON ... Gomperts SN (April 2016). "Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia". Continuum (Minneap ... progressive atypical Parkinsonism syndrome and is a tauopathy related to frontotemporal dementia. CBS is typically caused by ... Parmera JB, Rodriguez RD, Neto AS, Nitrini R, Brucki SM (2016). "Corticobasal syndrome: A diagnostic conundrum". Dementia ...
Dementia symptoms are also initially seen in about one in five cases of frontotemporal dementia. Other common early symptoms ... "Frontotemporal Dementias". Continuum. 22 (2 Dementia): 464-89. doi:10.1212/CON.0000000000000300. PMC 5390934. PMID 27042904. " ... "Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy". Dementia and ... PSP may be mistaken for other types of neurodegeneration such as Parkinson's disease, frontotemporal dementia and Alzheimer's ...
Frontotemporal dementia is the second most common form of early-onset dementia after Alzheimer's disease in people under the ... March 2012). "Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and ... Ratnavalli E, Brayne C, Dawson K, Hodges JR (June 2002). "The prevalence of frontotemporal dementia". Neurology. 58 (11): 1615- ... March 2012). "Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC ...
"Bruce Willis has frontotemporal dementia. These are the disease's symptoms". NBC News. February 18, 2023. Archived from the ... In February 2023, he was diagnosed with frontotemporal dementia. As a singer, Willis released his debut album, The Return of ... On February 16, 2023, Willis's family announced that he had been diagnosed with frontotemporal dementia. According to Dr. Gregg ...
Alzheimer's Disease and Frontotemporal Dementia. Methods in Molecular Biology. Vol. 670. pp. 263-74. doi:10.1007/978-1-60761- ...
Ratnavalli E, Brayne C, Dawson K, Hodges JR (June 2002). "The prevalence of frontotemporal dementia". Neurology. 58 (11): 1615- ... Mizielinska S, Isaacs AM (October 2014). "C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of ... or frontotemporal dementia (FTD). The second mechanism is through mutations that affect the expression of G-quadruplex binding ... "C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G- ...
Schizophrenia and frontotemporal dementia: Shared causation?, International Review of Psychiatry. International Review of ... shared genetic/epigenetic causation of psychiatric disorders and dementias, and others. In keeping with the LNI's priorities, ...
Such as Alzheimer's or frontotemporal dementia. Surface dyslexia is also a characteristic of semantic dementia, in which ... it is primarily associated with patients who have dementias. ...
The three clinical subtypes of frontotemporal lobar degeneration, frontotemporal dementia, semantic dementia and progressive ... Frontotemporal lobar degeneration (FTLD) is a pathological process that occurs in frontotemporal dementia. It is characterized ... frontotemporal dementia, mainly affects a frontomedian network discussed in the context of social cognition. Semantic dementia ... The Frontotemporal Dementia Syndromes. Cambridge University Press. 2007 ISBN 978-0-521-85477-1 OMIM entries on FRONTOTEMPORAL ...
... can occur in the context of frontotemporal dementia, a neurological disorder resulting from degeneration of the ... Mendez, M., Lauterbach, E., & Sampson, S. (2008). An evidence-based review of the psychopathology of frontotemporal dementia: a ... 2003). Moria and Witzelsu cht from Frontotemporal Dementia. Neuropsychopharmacology, 28, 1374-1382. ... There are a range of neuropsychiatric symptoms associated with frontal lobe dementia, including progressive declines in social ...
"Frontotemporal Dementia: Not the Protein We Thought". www.science.org. Retrieved 2022-04-04. Qin H, Lim LZ, Wei Y, Song J ( ... February 2018). "Disruption of ER-mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis ... and alpha-synuclein-negative frontotemporal dementia (FTLD-TDP, previously referred to as FTLD-U) and in amyotrophic lateral ... Mutations in the TARDBP gene are associated with neurodegenerative disorders including frontotemporal lobar degeneration and ...
... and frontotemporal dementia (FTD) also show commonalities with CBD. The types of imaging techniques that are most prominently ... Frontotemporal dementia can be an early feature. Neuropathological findings associated with CBD include the presence of ... Seritan AL, Mendez MF, Silverman DH, Hurley RA, Taber KH (2004). "Functional imaging as a window to dementia: Corticobasal ... CBS patients with greater temporoparietal degeneration are more likely to have AD pathology as opposed to frontotemporal lobar ...
Pickering-Brown S (2004). "The tau gene locus and frontotemporal dementia". Dementia and Geriatric Cognitive Disorders. 17 (4 ... "Phenotypic variation in frontotemporal dementia and parkinsonism linked to chromosome 17". Dementia and Geriatric Cognitive ... Rademakers R, Cruts M, van Broeckhoven C (October 2004). "The role of tau (MAPT) in frontotemporal dementia and related ... Goedert M, Spillantini MG (July 2000). "Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's ...
Ostberg P, Bogdanovic N, Fernaeus SE, Wahlund LO (November 2001). "Jargonagraphia in a case of frontotemporal dementia". Brain ...
"C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia". In Adam, Margaret P.; Ardinger, Holly H.; Pagon, ... Future opportunities to develop N-Acetyl-Leucine include Lewy body dementia, amyotrophic lateral sclerosis, restless leg ...
"An Investigation of Moral Judgement in Frontotemporal Dementia". Cognitive and Behavioral Neurology. 18 (4): 193-197. doi: ...
The 2006 discovery of the GRN mutation in a population of patients with frontotemporal dementia has spurred much research in ... GeneReviews/NCBI/NIH/UW entry on GRN-Related Frontotemporal Dementia (Articles with short description, Short description is ... April 2016). "Loss of exosomes in progranulin-associated frontotemporal dementia". Neurobiology of Aging. 40: 41-49. doi: ... Heterozygous mutation of the GRN gene leading to progranulin haploinsufficiency causes frontotemporal dementia. These mutations ...
There are documented cases of reversible frontotemporal dementia and coma. Coma due to a CSF leak has been successfully treated ... similar to behavioral-variant frontotemporal dementia as the frontal and temporal lobes are affected by downward sagging due to ... "Intracranial hypotension causing reversible frontotemporal dementia and coma". The Canadian Journal of Neurological Sciences. ...
In 2015, Kunkle was diagnosed with frontotemporal dementia. In the last few months of her life, she transitioned to a memory ...
"What is frontotemporal dementia". Dementia UK. Retrieved 2020-10-19. Finger, EC (April 2016). "Frontotemporal Dementias". ... Frontotemporal dementia (FTD), or frontotemporal degeneration disease, or frontotemporal neurocognitive disorder, encompasses ... Frontotemporal dementias are mostly early-onset syndromes that are linked to frontotemporal lobar degeneration (FTLD), which is ... The main subtypes of frontotemporal dementia are behavioral variant FTD, semantic dementia, progressive nonfluent aphasia, and ...
... is a rare form of dementia that is similar to Alzheimer disease, except that it tends to affect only certain areas of the brain ... is a rare form of dementia that is similar to Alzheimer disease, except that it tends to affect only certain areas of the brain ... Semantic dementia; Dementia - semantic; Frontotemporal dementia; FTD; Arnold Pick disease; Pick disease; 3R tauopathy; ... Frontotemporal dementia (FTD) is a rare form of dementia that is similar to Alzheimer disease, except that it tends to affect ...
Frontotemporal dementia / Picks disease - learn about symptoms, diagnosis, causes, risks and treatments and key differences ... About frontotemporal dementia. The nerve cell damage caused by frontotemporal dementia leads to loss of function in these brain ... Other terms you may see used to describe frontotemporal dementia include frontotemporal disorders, frontotemporal degeneration ... Frontotemporal dementia (FTD) or frontotemporal degeneration refers to a group of disorders caused by progressive nerve cell ...
... disease in focal areas of the cerebral cortex is the hallmark of the family of diseases referred to as frontotemporal dementia ... also termed frontotemporal lobar degeneration). Cases of elderly patients with progressive language deterioration have been ... Frontotemporal Dementia and Frontotemporal Lobar Degeneration * Sections Frontotemporal Dementia and Frontotemporal Lobar ... Frontotemporal Dementia and Frontotemporal Lobar Degeneration) and Frontotemporal Dementia and Frontotemporal Lobar ...
... is a term that covers a range of different mental health disorders that affect the frontal and temporal ... memory.ucsf.edu/dementia/ftd/behavioral-variant-frontotemporal-dementia *Kirshner H. S. (2014). Frontotemporal dementia and ... FAQs about frontotemporal dementia. How does frontotemporal dementia impact daily life?. FTD can have significant impacts on ... Frontotemporal dementia vs Vascular dementia - What is the difference?. These types of dementia are highly similar and can ...
... Neurology. 2012 Apr 24;78(17):1354-62. doi: ... We suggest the behavioral variant of frontotemporal dementia (bvFTD) as a specific disorder in which the reported deficits in ...
... disease in focal areas of the cerebral cortex is the hallmark of the family of diseases referred to as frontotemporal dementia ... also termed frontotemporal lobar degeneration). Cases of elderly patients with progressive language deterioration have been ... Frontotemporal Dementia and Frontotemporal Lobar Degeneration * Sections Frontotemporal Dementia and Frontotemporal Lobar ... Frontotemporal Dementia and Frontotemporal Lobar Degeneration) and Frontotemporal Dementia and Frontotemporal Lobar ...
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) is a condition that can affect the ... People with frontotemporal dementia initially may have trouble speaking, remembering words and names (dysnomia), and using ... Learn more about the gene associated with Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia. * ... Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A. ...
... and frontotemporal dementia (FTD). G-rich sequences have a propensity for forming highly stable quadruplex structures in both ... Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Picks ... Frontotemporal dementia (FTD) is one of the most common forms of young-onset dementia and is characterized by the progressive ... Lillo, P. & Hodges, J. R. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin ...
Frontotemporal Dementia: Genes, Images and Emotions. *Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects ( ... Forms of Frontotemporal Dementia. Based on the distinct patterns of signs and symptoms, three different clinical syndromes have ... been grouped together under the category of "frontotemporal dementia" (FTD):. *Behavioral variant frontotemporal dementia ( ... Frontotemporal dementia (FTD) is a group of related conditions resulting from the progressive degeneration of the temporal and ...
Common symptoms of frontotemporal dementia include personality changes, lack of social awareness and a decline in language ... The symptoms of frontotemporal dementia can be very different to memory loss and confusion which we may associate with more ... Frontotemporal dementia is a progressive disease. Over time symptoms get worse and someone will require more support to look ... In behavioural variant frontotemporal dementia, the parts of the frontal lobe that control social behaviour may be most ...
What is ftd dementia? Bruce Willis family described it as a cruel disease that many of us have never heard of and can strike ... What is frontotemporal dementia?. The family of Bruce Willis says frontotemporal dementia "is a cruel disease that many of us ...
The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review - Volume 43 Issue S1 ... DementiaAlzheimers DiseaseLewy Body DementiaFrontotemporal Dementiasystematic reviewmeta-analysis ... Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Picks ... Age-related incidence and family history in frontotemporal dementia: data from the Swedish Dementia Registry. PLoS One. 2014;9( ...
Did Hollywood legend Bruce Willis develop frontotemporal dementia (FTD) from the COVID-19 vaccine?! Here is what you need to ... Fact #4 : Frontotemporal Dementia Has Genetic Link. Frontotemporal dementia often has a genetic link. According to the ... Bruce Willis Got Frontotemporal Dementia From Vaccine!. After news broke that Bruce Willis was diagnosed with frontotemporal ... Fact #1 : Frontotemporal Dementia Was Diagnosis For Bruce Willis Aphasia. First, let us establish some basic facts about Bruce ...
The NACC Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) was used to determine dementia severity ... Among patients with frontotemporal dementia (FTD), racial disparities exist regarding severity, functional impairment, and ... Racial Disparities Identified in Presentation of Frontotemporal Dementia. October 3, 20230 ... "As FTD is rarer than AD, any disparities caused by decreased awareness of dementias or caused by decreased access to care might ...
Frontotemporal Dementia Risk Cohort (FTD-RisC) The FTD-RisC team is composed of prof. dr. John van Swieten, a neurologist and ... Frontotemporal Dementia Risk Cohort (FTD-RisC) The FTD-RisC team is composed of prof. dr. John van Swieten, a neurologist and ... Frontotemporal Dementia Risk Cohort (FTD-RisC) Status: Ongoing project Frontotemporal Dementia Risk Cohort (FTD-RisC) The FTD- ... Frontotemporal dementia (FTD) is a clinically heterogeneous neurodegenerative disorder characterized by prominent changes in ...
Frontotemporal Dementia (FTD) - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the Merck Manuals - ... Prognosis for Frontotemporal Dementia Frontotemporal dementias usually progress gradually, but progression rate varies; if ... Symptoms and Signs of Frontotemporal Dementia Generally, frontotemporal dementia affects personality, behavior, and usually ... Frontotemporal dementia accounts for up to 10% of dementias. Age at onset is typically younger (age 55 to 65) than in Alzheimer ...
International Neuropsychological Society • 2319 South Foothill Drive, Suite 260, Salt Lake City, Utah 84109, USA • 801-487-0475 • [email protected] ...
Dementia , Alzheimers Disease , Frontotemporal Dementia , New Approaches to Dementia Heterogeneity. ... Dementia, Mild Cognitive Impairment, Alzheimers Disease, *Healthy Volunteers, Frontotemporal Dementia Clinical Study ... o Have mild cognitive impairment, Alzheimers, or another form of dementia including behavioral variant frontotemporal dementia ... dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), or another rapidly progressive dementia. ...
These findings highlight the multifactorial nature of emotion processing deficits in patients with dementia. ... and semantic dementia [SD]) as well as those with Alzheimers disease (AD) show deficits on tests of face emotion processing, ... denoting a primary emotion processing disturbance in these dementia syndromes. ... Patients with frontotemporal dementia (both behavioural variant [bvFTD] ...
Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia ...
Apolipoprotein E, Isoforms, Alzheimers disease, Frontotemporal dementia. in Dementia and Geriatric Cognitive Disorders. volume ... Apolipoprotein E genotyping in Alzheimers disease and frontotemporal dementia. *Mark. Gustafson, Lars LU ; Abrahamson, Magnus ... Alzheimers disease (AD) and frontotemporal dementia (FTD) are characterized by progressive neuronal loss and ... Alzheimers disease (AD) and frontotemporal dementia (FTD) are characterized by progressive neuronal loss and ...
Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. Journal of Medical Genetics 2017;54: ...
... behavioural variant frontotemporal dementia; FTD, frontotemporal dementia; SP, slowly progressive. ... Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzhiemer disease. Cogn Behav Neurol ... Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006 ... Behavioral variant frontotemporal dementia: not all it seems? Neurocase 2007;13:237-47. ...
NIA have created mini-brains to model the sequence of deleterious events that leads to cell death in inherited frontotemporal ... Home News & Events Mini-brain model of frontotemporal dementia demonstrates the stages of dysfunction that lead to cell death ... Mini-brain model of frontotemporal dementia demonstrates the stages of dysfunction that lead to cell death November 04, 2021. ... of researchers were able to demonstrate the damaging changes that occur in brain cells of people with frontotemporal dementia ( ...
As news spread that actor Bruce Willis has been diagnosed with a disease known as frontotemporal dementia, heres what you ... t seem to be helpful for people with frontotemporal dementia, and some may worsen the symptoms of frontotemporal dementia. But ... What is frontotemporal dementia?. According to the Mayo Clinic's webpage on the condition, frontoptemporal dementia, also ... family announced that the actor has been diagnosed with a form of dementia called frontotemporal dementia (FTD). ...
Learn about Frontotemporal Dementia, including the symptoms, diagnoses, treatment options and our support programs. ... Frontotemporal dementia (FTD) is a type of dementia syndrome that has several variants. Depending on type of FTD, symptoms that ... We offer monthly support groups for care partners of individuals living with frontotemporal dementia and younger onset dementia ... There are several variants of FTD including primary progressive aphasia, behaviorial variant frontotemporal dementia, and more. ...
Get free answers on any health question about the condition Frontotemporal dementia from top U.S. doctors. Or, video chat with ... Mom has BV Frontotemporal dementia, gets btw. 3-6 UTIs a yr. because of poor hygiene practice. How will this affect her kidneys ... Will a MRI be able to show early onset Frontotemporal dementia? My mother has been diagnosed with FTD and I want to know if I ... In BV Frontotemporal dementia, how long does aggressive behavior last throughout the span of the disease? ...
  • Frontotemporal dementia (FTD), or frontotemporal degeneration disease, or frontotemporal neurocognitive disorder, encompasses several types of dementia involving the progressive degeneration of frontal and temporal lobes. (wikipedia.org)
  • Frontotemporal dementias are mostly early-onset syndromes that are linked to frontotemporal lobar degeneration (FTLD), which is characterized by progressive neuronal loss predominantly involving the frontal or temporal lobes, and a typical loss of more than 70% of spindle neurons, while other neuron types remain intact. (wikipedia.org)
  • There are a number of different diseases that cause frontotemporal degeneration. (alz.org)
  • Other terms you may see used to describe frontotemporal dementia include frontotemporal disorders, frontotemporal degeneration and frontal lobe disorders. (alz.org)
  • Primary progressive aphasia (PPA) is the second major form of frontotemporal degeneration that affects language skills, speaking, writing and comprehension. (alz.org)
  • The presentation of degenerative disease in focal areas of the cerebral cortex is the hallmark of the family of diseases referred to as frontotemporal dementia (also termed frontotemporal lobar degeneration). (medscape.com)
  • The condition described in the North American literature as primary progressive aphasia and that described in the European literature as frontal dementia have been combined under the term frontotemporal lobe dementia (FTD) or frontotemporal lobar degeneration (FTLD). (medscape.com)
  • An alternate term, frontotemporal lobar degeneration, relates to pathologies associated with the frontotemporal lobe dementia syndromes. (medscape.com)
  • Frontotemporal dementia (FTD) is one of the most common forms of young-onset dementia and is characterized by the progressive degeneration of the frontal and anterior temporal lobes, leading to changes in personality or language impairment 2 , 3 . (nature.com)
  • Frontotemporal dementia (FTD) is a group of related conditions resulting from the progressive degeneration of the temporal and frontal lobes of the brain. (ucsf.edu)
  • At autopsy, patients with lvPPA are often found to have Alzheimer's disease, not frontotemporal lobar degeneration (FTLD), the pathological description of FTD. (ucsf.edu)
  • The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. (nih.gov)
  • Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. (nih.gov)
  • Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. (nih.gov)
  • In conclusion, the revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotemporal lobar degeneration. (nih.gov)
  • His family announced the diagnosis on February 16, 2023, through a statement on the website of The Association for Frontotemporal Degeneration (AFTD). (rojakpot.com)
  • The NACC Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) was used to determine dementia severity, with higher scores indicating worse severity. (asbah.org)
  • Those living with Frontotemporal Degeneration should consider enrolling in a research program affiliated with the center. (northwestern.edu)
  • Frontotemporal Degeneration, Alzheimer's, and Dementia are diseases with no cure, minimal treatments, and have a deep impact on families and caretakers. (brightfunds.org)
  • FTD is also known as Pick's disease or frontotemporal lobar degeneration. (disabledentrepreneur.uk)
  • hence the term frontotemporal lobar degeneration. (capsulehealth.one)
  • Objective: To determine whether cases of frontotemporal lobar degeneration (FTLD) do exist in elderly individuals and have clinical and neuropathological features distinct from those with presenile onset. (ncl.ac.uk)
  • Conclusions: Frontotemporal lobar degeneration in elderly patients does exist as a separate entity from presenile-onset FTLD. (ncl.ac.uk)
  • Frontotemporal lobar degeneration (FTLD) is the medical term for a group of neurodegenerative disorders characterised by focal atrophy of the frontal and/or temporal cortices. (bestbulksmsonline.com)
  • In behavioural variant frontotemporal dementia, the parts of the frontal lobe that control social behaviour may be most affected. (alzheimersresearchuk.org)
  • Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. (nih.gov)
  • According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). (nih.gov)
  • Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. (nih.gov)
  • Background Some patients meeting behavioural variant frontotemporal dementia (bvFTD) diagnostic criteria progress slowly and plateau at mild symptom severity. (bmj.com)
  • Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative clinical syndrome characterised by insidious behavioural and personality changes. (bmj.com)
  • However, as research shed light on this condition and related neurodegenerative diseases, Pick's disease was grouped with semantic dementia and primary progressive aphasia under the umbrella term frontotemporal dementia. (mentalhealth.com)
  • There are several variants of FTD including primary progressive aphasia, behaviorial variant frontotemporal dementia, and more. (northwestern.edu)
  • Two types of primary progressive aphasia are identified: (1) semantic dementia, in which meaning systems are lost from language, and (2) nonfluent primary progressive aphasia. (medscape.com)
  • Frontotemporal dementia (FTD) is a rare form of dementia that is similar to Alzheimer disease , except that it tends to affect only certain areas of the brain. (medlineplus.gov)
  • However, FTD typically presents much earlier than dementia and is the most common form of dementia for people 60 years old and younger. (mentalhealth.com)
  • For people under 60, FTD is the most common form of dementia, and because getting the diagnosis can take years, FTD is likely much more prevalent than we know. (rojakpot.com)
  • Racial differences have the potential to impact disease presentation in any form of dementia due to socioeconomic, cultural, and structural factors. (asbah.org)
  • FTD is a form of dementia that can cause behavioral changes, trouble with communication, and movement problems. (nih.gov)
  • family announced that the actor has been diagnosed with a form of dementia called frontotemporal dementia (FTD). (wogx.com)
  • Alzheimer disease (AD) is the most common form of dementia. (adam.com)
  • Frontotemporal Dementia (FTD) is a form of dementia that primarily affects the frontal and temporal lobes of the brain. (disabledentrepreneur.uk)
  • It is a relatively rare form of dementia, accounting for about 5-10% of all dementia cases, and typically occurs in people aged 40-75 years old. (disabledentrepreneur.uk)
  • Changes to the eyes might help diagnose the onset of frontotemporal dementia, the second most common form of dementia, according to new research from scientists at the University of Alabama at Birmingham, Gladstone Institutes and the University of California, San Francisco. (blogspot.com)
  • In addition to more typical symptoms like memory loss, people with this form of dementia may have movement or balance problems like stiffness or trembling. (cdc.gov)
  • Behavioral variant frontotemporal dementia (BvFTD) was previously known as Pick's disease, and is the most common of the FTD types. (wikipedia.org)
  • Behavioral variant frontotemporal dementia (bvFTD), sometimes also called behavior variant FTD, is characterized by prominent changes in personality and behavior that often occur in people in their 50s and 60s, but can develop as early as their 20s or as late as their 80s. (alz.org)
  • Patients with frontotemporal dementia (both behavioural variant [bvFTD] and semantic dementia [SD]) as well as those with Alzheimer's disease (AD) show deficits on tests of face emotion processing, yet the mechanisms underlying these deficits have rarely been explored. (hindawi.com)
  • Some bvFTD-SP patients may have neurodegenerative pathology, and C9ORF72 mutations should be considered in patients with bvFTD-SP and a family history of dementia or motor neuron disease. (bmj.com)
  • FTD is the second most prevalent type of early onset dementia after Alzheimer's disease. (wikipedia.org)
  • Both behavioral variant frontotemporal dementia and PPA are far less common than Alzheimer's disease in those over the age of 65. (alz.org)
  • In people under age 60, FTD is the most common cause of dementia and affects as many people as Alzheimer's disease in the 45-64 age group. (ucsf.edu)
  • Due to the symptoms, people with FTD are often misdiagnosed with Alzheimer's disease , psychiatric problems (such as depression, manic-depression, obsessive-compulsive disease or schizophrenia), vascular dementia or Parkinson's disease . (ucsf.edu)
  • It remains to be determined if the disparities observed in Alzheimer's Disease and other forms of dementia are the same as those in FTD. (asbah.org)
  • Alzheimer's disease (AD) and frontotemporal dementia (FTD) are characterized by progressive neuronal loss and microvacuolization, although with different distributions of cortical involvement. (lu.se)
  • article{44e2a954-7880-4bd4-8772-2961f44222d7, abstract = {{Alzheimer's disease (AD) and frontotemporal dementia (FTD) are characterized by progressive neuronal loss and microvacuolization, although with different distributions of cortical involvement. (lu.se)
  • Learn about the progression and stages of dementia, including Alzheimer's disease and Frontotemporal Dementia (FTD), in this comprehensive article. (medriva.com)
  • Explore the different types of dementia, including Alzheimer's disease, frontotemporal dementia (FTD), and vascular dementia. (medriva.com)
  • Learn about the early signs and symptoms of dementia, including Alzheimer's disease and Frontotemporal Dementia (FTD). (medriva.com)
  • Frontotemporal dementia is a progressive neurodegenerative syndrome, and the second most common cause of young-onset dementia after Alzheimer's disease. (healthresearchbc.ca)
  • Alzheimer's disease is the most common type of dementia. (cdc.gov)
  • For example, a person may have Alzheimer's disease and vascular dementia. (cdc.gov)
  • The major causes of dementia are neurodegenerative diseases of aging, including Alzheimer's disease, Parkinson's disease and frontotemporal dementia. (lu.se)
  • Alzheimer's disease is the leading cause of dementia. (lu.se)
  • In the Experimental Dementia Research Unit we work to uncover the cell biological and pathological basis of dementia, with a focus on Alzheimer's disease. (lu.se)
  • The most common cause of dementia is Alzheimer's Disease (AD) accounting for 60% to 70% of cases, followed by vascular dementia, dementia with Lewy bodies, and frontotemporal dementia 1-2 . (bvsalud.org)
  • The main subtypes of frontotemporal dementia are behavioral variant FTD, semantic dementia, progressive nonfluent aphasia, and FTD associated with amyotrophic lateral sclerosis (FTD-ALS). (wikipedia.org)
  • Semantic dementia (SD) is characterized by the loss of semantic understanding, resulting in impaired word comprehension. (wikipedia.org)
  • The progressive aphasias have been divided into 3 groups: progressive nonfluent aphasia, semantic dementia, and logopenic progressive aphasia. (medscape.com)
  • In semantic dementia, the parts of the temporal lobe that support understanding of language and factual knowledge are most affected. (alzheimersresearchuk.org)
  • B . Semantic dementia , people speak easily, but their words convey less and less meaning. (org.tt)
  • The goal of this article consists in the review of studies about the discourse patterns presented by persons with two subtypes of frontotemporal dementia (frontal variant - DFT - and semantic dementia - DS) and dementia of the Alzheimer's type (DTA). (bvsalud.org)
  • In behavioral variant frontotemporal dementia, the nerve cell loss is most prominent in areas that control conduct, judgment, empathy and foresight, among other abilities. (alz.org)
  • However, in the 45 to 65 age range, behavioral variant frontotemporal dementia and PPA are nearly as common as younger-onset Alzheimer's . (alz.org)
  • Only rough estimates are available, but there may be 50,000 to 60,000 people with behavioral variant frontotemporal dementia and PPA in the United States, the majority of whom are between 45 and 65 years of age. (alz.org)
  • The diagnosis of behavioral variant frontotemporal dementia and PPA are based on expert evaluation by a doctor who is familiar with these disorders. (alz.org)
  • It is common for a person with behavioral variant FTD dementia to struggle with planning and organizing or making decisions. (org.tt)
  • Neuropsychiatric symptoms and imbalance of atrophy in behavioral variant frontotemporal dementia. (bvsalud.org)
  • Behavioral variant frontotemporal dementia is characterized by heterogeneous frontal, insular, and anterior temporal atrophy patterns that vary along left-right and dorso-ventral axes. (bvsalud.org)
  • Neuropsychiatric symptoms and structural images were analyzed for 250 patients with behavioral variant frontotemporal dementia . (bvsalud.org)
  • This study provides additional insight into how anatomical heterogeneity influences the clinical presentation of patients with behavioral variant frontotemporal dementia . (bvsalud.org)
  • Neuropathologically, the group of elderly patients with FTLD comprised 7 with FTLD-TDP-43, 1 with ubiquitin-positive FTLD, 2 with FTLD-tau/Pick disease, and 1 with FTLD-tau/neurofibrillary tangle-predominant dementia with TDP-43, a composition similar to presenile-onset FTLD. (ncl.ac.uk)
  • Elderly patients with FTLD represented 3.2% of all elderly patients with dementia autopsied at Newcastle General Hospital. (ncl.ac.uk)
  • Large expansions of a non-coding GGGGCC-repeat in the first intron of the C9orf72 gene are a common cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). (nature.com)
  • See Targeted Genes and Methodology Details for Inherited Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Gene Panel and Method Description for additional details. (mayocliniclabs.com)
  • Identification of a disease-causing variant may assist with diagnosis, prognosis, clinical management, recurrence risk assessment, familial screening, and genetic counseling for frontotemporal dementia and/or amyotrophic lateral sclerosis. (mayocliniclabs.com)
  • First tier testing for a diagnosis of dementia or amyotrophic lateral sclerosis is C9ORF / C9orf72 , Hexanucleotide Repeat, Molecular Analysis, Varies, which is included with this test but is also available separately. (mayocliniclabs.com)
  • Neurodegenerative disorders (NDDs) such as Huntington's disease (HD) and the spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by progressive loss of selectively vulnerable populations of neurons. (lu.se)
  • [1] [2] These are the four motor symptoms found in Parkinson's disease (PD) - after which it is named - dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD), and many other conditions. (wikipedia.org)
  • In recent years, the term frontotemporal dementia has become an umbrella term referring to clinical syndromes of frontal dementia or progressive aphasia. (medscape.com)
  • Importantly, all groups remained impaired on one task or more following these analyses, denoting a primary emotion processing disturbance in these dementia syndromes. (hindawi.com)
  • Theis results in a set of clinical manifestations known collectively as frontotemporal dementia (FTD) syndromes. (bestbulksmsonline.com)
  • Dementia syndromes are often degenerative and progressive comorbidities involving great mental, physical and psychological disorders. (bvsalud.org)
  • Frontotemporal dementia (FTD), also known as Pick's disease, is caused by clumps of abnormal tau or TDP43 proteins forming inside brain cells. (rojakpot.com)
  • Unraveling the Mysteries of Dementia: A Comprehensive Guide to Alzheimer's, FTD, Vascular Dementia, and More. (medriva.com)
  • When he saw Mr. Karger in 2007, the diagnosis was clear within the hour: Mr. Karger had a type of frontotemporal dementia. (iage.com)
  • For example, Pick disease is a term used to describe some of the changes in the brain caused by a specific type of frontotemporal dementia. (msdmanuals.com)
  • According to the Mayo Clinic, there are genetic mutations that have been linked to FTD, while also noting that more than half of those who develop FTD have no family history of dementia. (wogx.com)
  • As many as 50% of patients with frontotemporal dementia have a positive family history of dementia and inherit frontotemporal dementia as an autosomal dominant trait with high penetrance. (medscape.com)
  • Most individuals diagnosed with the disorder have had an affected parent with the clinical symptoms of frontotemporal dementia. (asperbio.com)
  • Frontotemporal dementia (FTD) is a heterogeneous clinical, genetic, and neuropathological disorder. (unimi.it)
  • Diagnostic markers are key in clinical trials to differentiate FTD from other neurodegenerative dementias. (unimi.it)
  • Molecular pathologies and phenotypic correlations in frontotemporal dementia (FTD): The schematic shows major genes causing frontotemporal dementia, histopathological substrates, and clinical phenotypes. (capsulehealth.one)
  • The long-term goal of the project is to bring new drugs for frontotemporal dementia into clinical trials. (healthresearchbc.ca)
  • The goal of this study was to assess the frequency of frontotemporal asymmetry (right- or left-lateralization) and dorsality (ventral or dorsal predominance of atrophy ) and to investigate their clinical correlates. (bvsalud.org)
  • Pick disease (named after Arnold Pick) is a progressive dementia defined by clinical and pathologic criteria. (medscape.com)
  • Dementia is a clinical syndrome of cognitive decline that includes a range of cognitive and behavioural symptoms caused by a variety of underlying pathophysiological processes. (bvsalud.org)
  • Pick disease is one of the disorders classified under the term frontotemporal dementia (FTD). (medscape.com)
  • The disorders grouped under frontotemporal dementia fall into three subtypes (discussed below). (alz.org)
  • Further, it presents the main cognitive features of the subtypes of dementia in focus. (bvsalud.org)
  • Finally, the relations between the discourse features and the cognitive and neurological damage in these dementia subtypes are discussed. (bvsalud.org)
  • Frontotemporal dementia used to be called Pick's disease after Arnold Pick, M.D., a physician who in 1892 first described a patient with distinct symptoms affecting language. (alz.org)
  • This can be referred to as Pick's disease or frontal lobe dementia. (org.tt)
  • Frontotemporal dementia (FTD) is a degenerative condition characterized by progressive neuronal loss in the temporal and frontal lobes of the brain. (asperbio.com)
  • In June 2016, the Executive Board in decision EB139(1) requested the Director-General to develop with the full participation of Member States and in cooperation with other relevant stakeholders a draft global action plan on the public health response to dementia, with clear goals and targets, for consideration by the Seventieth World Health Assembly, through the Executive Board at its 140th session. (who.int)
  • 1 Availab le at http://www.who.int/mental_health/action_plan_2013/en/ (accessed 22 November 2016). (who.int)
  • 2 Availab le at http://www.who.int/nmh/publications/ncd-action-plan/en/ (a ccessed 22 November 2016). (who.int)
  • 3 Availab le at http://www.who.int/disabilities/actionplan/en/ (accessed 22 November 2016). (who.int)
  • 4 Availab le at http://www.who.int/ageing/global-strategy/en/ (accessed 22 November 2016). (who.int)
  • 5 Availab le at http://www.who.int/hrh/resources/globstrathrh-2030/en/ (a ccessed 22 November 2016). (who.int)
  • 6 Availab le at http://www.paho.org/hq/index.php?option=com_content&view=article&id=11087%3A2015-54th- directing-council&catid=8811%3Adc-documents&Itemid=41537&lang=en (a ccessed 22 November 2016). (who.int)
  • We have updated several neurological panels, including Charcot-Marie-Tooth Disease , Frontotemporal Dementia , and Parkinson's Disease . (asperbio.com)
  • However, the neural basis of olfactory dysfunction, the effect of concurrent cognitive deficits on olfactory testing results, and the exact prevalence of olfactory deficits in populations with corticobasal syndrome (CBS) and the frontal variant of frontotemporal dementia (FTD-FV) are to date unclear. (northwestern.edu)
  • Frontotemporal dementia (FTD) is a clinically heterogeneous neurodegenerative disorder characterized by prominent changes in social behavior and personality or aphasia. (erasmusmc.nl)
  • Clinically and pathologically heterogeneous group of non-Alzheimer dementias characterised collectively by relatively selective, progressive atrophy involving the frontal or temporal lobes, or both. (capsulehealth.one)
  • In a clinicopathologic series, only 5% of patients with clinically diagnosed frontotemporal dementia had classic Pick disease with Pick bodies at postmortem evaluation. (medscape.com)
  • In families with an inherited frontal lobe dementia (some of which have been found to be pathologically or clinically indistinguishable from Pick disease), linkage to markers on chromosomes 17, 9, and 3 have been reported. (medscape.com)
  • Frontotemporal dementia is an early-onset disorder that mostly occurs between the ages of 45 and 65, but can begin earlier, and in 20-25% of cases onset is later. (wikipedia.org)
  • Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD) is a condition that can affect the muscles, bones, and brain. (medlineplus.gov)
  • Dementia affects mainly memory, is typically caused by anatomic changes in the brain, has slower onset, and is generally irreversible. (merckmanuals.com)
  • We offer monthly support groups for care partners of individuals living with frontotemporal dementia and younger onset dementia. (northwestern.edu)
  • The age of onset for Frontotemporal Dementia can vary widely, ranging from as early as 40 years of age, with and average onset age of 54. (bestbulksmsonline.com)
  • Frontotemporal dementia (FTD) is a group of brain disorders caused by atrophy of the frontal and temporal lobes. (mentalhealth.com)
  • Frontotemporal dementia (FTD) refers to sporadic and hereditary disorders that affect the frontal and temporal lobes, including Pick disease. (merckmanuals.com)
  • Overview of Delirium and Dementia Delirium (sometimes called acute confusional state) and dementia are the most common causes of cognitive impairment, although affective disorders (eg, depression) can also disrupt cognition. (merckmanuals.com)
  • According to the Mayo Clinic's webpage on the condition, frontoptemporal dementia, also known as FTD, is an umbrella term for a group of brain disorders that primarily affect the frontal and temporal lobes of the brain. (wogx.com)
  • Frontotemporal dementia, which refers to a group of dementias, results from hereditary or spontaneous (occurring for unknown reasons) disorders that cause the frontal and sometimes the temporal lobe of the brain to degenerate. (msdmanuals.com)
  • Facilitate differential diagnosis between psychiatric disorders (depression, schizophrenia) and frontotemporal dementia through the use of blood-based biomarkers. (lu.se)
  • This study is looking for adults who have mild cognitive impairment, Alzheimer's, or other forms of dementia. (centerwatch.com)
  • The study is interested in the ways that brain function changes over time in various forms of dementia. (centerwatch.com)
  • First, let us establish some basic facts about Bruce Willis, his earlier diagnosis of aphasia, and the new diagnosis of frontotemporal dementia (FTD). (rojakpot.com)
  • Since we announced Bruce's diagnosis of aphasia in spring 2022, Bruce's condition has progressed and we now have a more specific diagnosis: frontotemporal dementia (known as FTD). (rojakpot.com)
  • This new diagnosis of frontotemporal dementia dismisses the earlier claims that his aphasia was somehow caused by the COVID-19 vaccine . (rojakpot.com)
  • Learn about the symptoms, causes, and diagnosis of frontotemporal dementia - a lesser-known but concerning type of degenerative brain disorder. (medriva.com)
  • Imaging commonly shows atrophy in the frontotemporal region, and in part of the striatum in the basal ganglia. (wikipedia.org)
  • Frontotemporal atrophy was most often symmetric while left-lateralized (9%) and right-lateralized (17%) atrophy were present in a minority of patients . (bvsalud.org)
  • The family of Bruce Willis says frontotemporal dementia "is a cruel disease that many of us have never heard of and can strike anyone. (khou.com)
  • Did Bruce Willis Get Frontotemporal Dementia From Vaccine? (rojakpot.com)
  • Did Hollywood legend Bruce Willis develop frontotemporal dementia (FTD) from the COVID-19 vaccine? (rojakpot.com)
  • After news broke that Bruce Willis was diagnosed with frontotemporal dementia (FTD), people immediately claimed that the legendary Hollywood actor got it from the COVID-19 vaccine! (rojakpot.com)
  • Subsequently, the PPA syndrome was defined as a disorder limited to progressive aphasia, without general cognitive impairment or dementia, over a 2-year period. (medscape.com)
  • Frontotemporal dementia (FTD) is a type of dementia syndrome that has several variants. (northwestern.edu)
  • Progressive nonfluent aphasia - Known as nfvPPA, this type of FTD dementia affects one's ability to produce speech, which becomes increasingly halting. (mentalhealth.com)
  • Dementia affects mainly memory, and delirium affects mainly attention. (msdmanuals.com)
  • Frontotemporal dementia (FTD) is a type of dementia that affects the frontal and temporal lobes of the brain. (disabledentrepreneur.uk)
  • Frontotemporal dementia affects the frontal and temporal lobes, which are located in the front and on the sides of the brain. (greatergood.com)
  • Though dementia mostly affects older adults, it is not a part of normal aging. (cdc.gov)
  • This type of dementia most often leads to changes in personality and behavior because of the part of the brain it affects. (cdc.gov)
  • Overview of Delirium and Dementia Delirium and dementia are the most common causes of mental (cognitive) dysfunction-the inability to acquire, retain, and use knowledge normally. (msdmanuals.com)
  • Dementia defines a category of diseases characterized by progressive and debilitating decline in cognitive functions. (lu.se)
  • There are a wide variety of signs and symptoms of different types of dementia, and science is still discovering new ones on a regular basis. (greatergood.com)
  • The nerve cell damage caused by frontotemporal dementia leads to loss of function in these brain regions, which variably cause deterioration in behavior, personality and/or difficulty with producing or comprehending language. (alz.org)
  • IBMPFD is associated with a brain condition called frontotemporal dementia, which becomes noticeable in a person's forties or fifties. (medlineplus.gov)
  • The early symptoms of frontotemporal FTD vary from person to person and depend on which area of the brain is affected first. (alzheimersresearchuk.org)
  • The study is interested in the ways that brain function changes over time with the goal of improving the ability to diagnose and care for dementia. (centerwatch.com)
  • Using a new mini-brain model, a large team of researchers were able to demonstrate the damaging changes that occur in brain cells of people with frontotemporal dementia (FTD). (nih.gov)
  • Dementia is a loss of brain function that occurs with certain diseases. (adam.com)
  • When progranulin production ends too early, it leads to a shortened protein that cannot carry out the normal brain functions, eventually leading to dementia in the sixth decade. (healthresearchbc.ca)
  • About 10 percent of dementia cases are linked to strokes or other issues with blood flow to the brain. (cdc.gov)
  • Sometimes more than one type of dementia is present in the brain at the same time, especially in people aged 80 and older. (cdc.gov)
  • For patient education information, see the Brain and Nervous System Center, as well as Pick Disease and Dementia Medication Overview. (medscape.com)
  • Visual assessment of brain perfusion MRI scans in dementia: a pilot study. (lu.se)
  • Sometimes, people with FTD take the same medicines used to treat other types of dementia. (medlineplus.gov)
  • People with frontotemporal dementia initially may have trouble speaking, remembering words and names (dysnomia), and using numbers (dyscalculia). (medlineplus.gov)
  • As the dementia worsens, affected people ultimately become unable to speak, read, or care for themselves. (medlineplus.gov)
  • Drugs used to treat or slow Alzheimer's disease don't seem to be helpful for people with frontotemporal dementia, and some may worsen the symptoms of frontotemporal dementia. (wogx.com)
  • Frontotemporal dementia attacks people in their fifth or sixth decade, just as retirement comes within reach. (iage.com)
  • Typically, the dementia develops in people younger than 65. (msdmanuals.com)
  • People with a frontotemporal dementia also have difficulty thinking abstractly, paying attention, and recalling what they have been told. (msdmanuals.com)
  • By commingling the carts and symptoms to summarize, support and be their workouts anti-life, Network Solutions grades 30 punjabi of leading download hodges␙ frontotemporal dementia to sanitize People be in an instantly bottom stellvertretende. (unicomelectronic.com)
  • People with frontotemporal dementia may also suffer from a decrease in their executive function abilities, meaning they'll struggle to properly plan a task or create a logical sequence of events. (greatergood.com)
  • One in every two or three people with frontotemporal dementia has a family history of the disease. (greatergood.com)
  • The draft plan includes actions in line with the Convention on the Rights of Persons with Disabilities as applicable to people with dementia. (who.int)
  • This is the most common cause of dementia, accounting for 60 to 80 percent of cases. (cdc.gov)
  • These findings highlight the multifactorial nature of emotion processing deficits in patients with dementia. (hindawi.com)
  • In 1982, Mesulam reported 6 patients with progressive aphasia, gradually worsening over a number of years, who did not develop a more generalized dementia. (medscape.com)
  • It was only later that the cause of that aphasia was finally determined - frontotemporal dementia (FTD). (rojakpot.com)
  • He suffered from aphasia (a symptom), and was later diagnosed with the actual cause - frontotemporal dementia (FTD). (rojakpot.com)
  • Frontotemporal dementia is a progressive disease. (alzheimersresearchuk.org)
  • appear late in the disease but also occur in other dementias. (merckmanuals.com)
  • Dementia is not a specific disease but is rather a general term for the impaired ability to remember, think, or make decisions that interferes with doing everyday activities. (cdc.gov)